Processing 00000000.tx.1: Diabetes Alters the Occupancy of the Hepatic 3-Hydroxy-3-methylglutaryl-CoA Reductase Promoter* William R. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "Alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the Occupancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827063:Occupancy [Qualitative Concept]

Phrase: "of the Hepatic 3-Hydroxy-3-methylglutaryl-CoA Reductase Promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "* William R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: Lagor, Eric D. de Groh, and Gene C. 

Phrase: "Lagor,"

Phrase: "Eric D. de Groh,"

Phrase: "and"

Phrase: "Gene C."
Processing 00000000.tx.3: Ness1 From the Department of Biochemistry and Molecular Biology, University of South Florida College of Medicine, Tampa, Florida 33612 Received for publication, April 20, 2005 , and in revised form, July 14, 2005.  

Phrase: "Ness1 From the Department of Biochemistry"

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "University of South Florida College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0557806:College [Manufactured Object]

Phrase: "Tampa,"

Phrase: "Florida 33612"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016253:Florida [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "April 20,"

Phrase: "2005 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "July 14,"

Phrase: "2005."
Processing 00000000.tx.4: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Hepatic 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) protein and mRNA are substantially decreased in diabetic animals and rapidly restored by the administration of insulin. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hepatic 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   892   C1840635:HEPATIC PROTEIN [Gene or Genome]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "substantially"

Phrase: "decreased in diabetic animals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0003062:Animals [Animal]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "restored by the administration of insulin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0199782:Administration of insulin [Therapeutic or Preventive Procedure]
           administration insulin
   753   C0001554:Administration [Occupational Activity]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.5: To begin to examine the underlying molecular mechanisms, measurements of transcription by nuclear run-on assays and an investigation of occupancy of the promoter were performed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the underlying molecular mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "measurements of transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0242485:measurements [Functional Concept]

Phrase: "by nuclear run-on assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1519116:Run-On Assays [Molecular Biology Research Technique]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "an investigation of occupancy of the promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1261322:Investigation [Health Care Activity]
   748   C1552578:investigation [Idea or Concept]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.6: The rate of transcription was substantially reduced in the diabetic rats and fully restored within 2 h after insulin treatment. 

Phrase: "The rate of transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "substantially"

Phrase: "reduced in the diabetic rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0241863:DIABETIC [Finding]
   760   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "fully"

Phrase: "restored within 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "after insulin treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.7: In vivo footprinting revealed several areas of protein binding as shown by dimethyl sulfate protection or enhancement. 

Phrase: "In vivo footprinting revealed several areas of protein binding"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0205146:areas [Spatial Concept]
   708 E C0017446:Area [Geographic Area]

Phrase: "as"

Phrase: "shown by dimethyl sulfate protection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0058229:Dimethylsulfate [Hazardous or Poisonous Substance,Organic Chemical]
   760   C0038720:Sulfate [Inorganic Chemical]
   760   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   760   C1545588:Protection [Finding]
   760   C3536965:SULFATE [Element, Ion, or Isotope]
   726   C1547282:Show [Intellectual Product]

Phrase: "or"

Phrase: "enhancement."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1627358:Enhancement [Therapeutic or Preventive Procedure]
  1000   C2349975:Enhancement [Activity]
Processing 00000000.tx.8: The cAMP-response element was heavily protected in all conditions, including diabetes, feeding of dietary cholesterol, or statin treatment. 

Phrase: "The cAMP-response element"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1511573:cAMP Response Element [Gene or Genome]
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "heavily"

Phrase: "protected in all conditions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "feeding of dietary cholesterol,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0008395:Cholesterol, Dietary [Steroid]
   770   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   770   C0012155:Dietary [Food]
   770   C0204695:Feeding [Health Care Activity]
   770   C2699635:DIETARY [Functional Concept]
   770   C2987508:Feeding [Activity]

Phrase: "or"

Phrase: "statin treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.9: Striking enhancements in footprints from diabetic animals were visible at 142 and at 161 (in the sterol-response element). 

Phrase: "Striking enhancements in footprints"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   737   C2349975:Enhancement [Activity]

Phrase: "from diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "visible at 142"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205379:Visible [Qualitative Concept]

Phrase: "and at 161"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "("

Phrase: "in the sterol-response element"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: ")."
Processing 00000000.tx.10: Protections at a newly identified NF-Y site at 70/71 were observed in normal animals and not in diabetics. 

Phrase: "Protections at a newly identified NF-Y site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1545588:Protection [Finding]

Phrase: "at 70/71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "were"

Phrase: "observed in normal animals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003062:Animals [Animal]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "not in diabetics."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0241863:diabetics [Finding]
   790   C1518422:Not [Functional Concept]
Processing 00000000.tx.11: This NF-Y site was found to be required for efficient HMGR transcription in luciferase assays. 

Phrase: "This NF-Y site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "required for efficient HMGR transcription"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0040649:Transcription [Genetic Function]
   742   C0442799:Efficient [Qualitative Concept]
   742   C0700307:Hydroxy [Inorganic Chemical]
   742   C1514873:Required [Functional Concept]

Phrase: "in luciferase assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.12: CREB-1 was able to bind the HMGR cAMP-response element in vitro and the promoter in vivo. 

Phrase: "CREB-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1447703:CREB-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the HMGR cAMP-response element"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   835   C1511573:cAMP Response Element [Gene or Genome]
   812   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0013879:Element [Element, Ion, or Isotope]
   793   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   793   C0871261:Response [Organism Attribute]
   793   C1704632:Response [Finding]
   793   C1705248:Element [Conceptual Entity]
   793   C1706817:Response [Intellectual Product]
   793   C2911692:Response [Mental Process]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "the promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.13: This evidence supports an essential role for cAMP-response element-binding protein in transcription of hepatic HMGR and identifies at least two sites where in vivo occupancy is regulated by insulin.  

Phrase: "This evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "an essential role for cAMP-response element-binding protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "of hepatic HMGR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "identifies at least two sites where in vivo occupancy"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   764   C1515655:In Vivo [Spatial Concept]
           vivo
   742   C0205145:Sites [Spatial Concept]
   742   C0205448:Two [Quantitative Concept]
   742   C2827063:Occupancy [Qualitative Concept]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "regulated by insulin."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Type I diabetes is associated with lower rates of cholesterol synthesis and increased absorption of dietary cholesterol in humans (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Type I diabetes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type I [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "associated with lower rates of cholesterol synthesis"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0599474:cholesterol synthesis [Molecular Function]
   748   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   748   C0220781:synthesis [Biologic Function]
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C1883254:Synthesis [Activity]
   748   C2003888:Lower [Activity]
   714 E C0750490:Associate [Idea or Concept]
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "increased absorption of dietary cholesterol"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   835   C1372253:Increased Cholesterol Absorption [Organ or Tissue Function]
   797   C2945742:absorption cholesterol [Cell Function]
   760   C0000854:Absorption [Natural Phenomenon or Process]
   760   C0220777:absorption [Functional Concept]
   760   C2347023:Absorption [Phenomenon or Process]
   760   C2347080:Absorption [Phenomenon or Process]
   760   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   760   C2825050:Absorption [Phenomenon or Process]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: These individuals are at high risk for the development of cardiovascular disease (2) and have higher total serum cholesterol levels. 

Phrase: "These individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "are at high risk"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0332167:High Risk [Qualitative Concept]
   833   C3272283:High Risk [Finding]
   770   C0035647:Risk [Qualitative Concept]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C1551058:Are [Quantitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "for the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of cardiovascular disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007222:Cardiovascular disease [Disease or Syndrome]
   861   C0007226:Cardiovascular [Body System]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "have"

Phrase: "higher total serum cholesterol levels."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   877   C1522133:high cholesterol level [Finding]
           high cholesterol
   853   C0201950:Total Cholesterol [Laboratory Procedure]
           cholesterol levels
   853   C0543421:Total cholesterol [Steroid]
   851   C0587184:Serum cholesterol level [Laboratory Procedure]
           serum cholesterol
   851   C1287371:Serum cholesterol level [Laboratory or Test Result]
   840   C0428466:cholesterol levels [Laboratory or Test Result]
   804   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   804   C0229671:Serum [Body Substance]
   804   C0441889:Levels [Qualitative Concept]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.16: In rats, streptozotocin-induced diabetes also renders animals particularly susceptible to a dietary cholesterol insult (3). 

Phrase: "In rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "streptozotocin-induced diabetes also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0038433:Streptozotocin Diabetes [Experimental Model of Disease]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]

Phrase: "renders"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "particularly susceptible to a dietary cholesterol insult"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0231204:Susceptible [Functional Concept]
   748   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: For reasons that are still unclear, this sensitivity correlates well with decreased expression of hepatic HMG2-CoA reductase (4), the enzyme that catalyzes the rate-limiting reaction in cholesterol biosynthesis. 

Phrase: "For reasons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:reasons [Idea or Concept]

Phrase: "that"

Phrase: "are"

Phrase: "still unclear,"

Phrase: "this sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]

Phrase: "correlates"

Phrase: "well with decreased expression of hepatic HMG2-CoA reductase"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   742   C0019800:HMG2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205054:Hepatic [Body Location or Region]
   742   C0205170:Well [Qualitative Concept]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C1333909:HMG2 [Gene or Genome]
   742   C3146287:Well [Manufactured Object]
   708 E C0547047:Decrease [Quantitative Concept]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "that"

Phrase: "catalyzes"

Phrase: "the rate-limiting reaction in cholesterol biosynthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0678608:rate reaction [Temporal Concept]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.18: Hepatic HMG-CoA reductase is responsible for the majority of the regulatable cholesterol synthesis in the body. 

Phrase: "Hepatic HMG-CoA reductase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415615:HMG-CoA REDUCTASE [Gene or Genome]
   861   C0047420:HMG-CoA [Biologically Active Substance,Organic Chemical]
   812   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "responsible for the majority of the regulatable cholesterol synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]

Phrase: "in the body."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242821:body [Human]
  1000   C0460148:Body [Anatomical Structure]
  1000   C1268086:Body [Anatomical Structure]
   916 E C1995017:Bodies [Cell Component]
Processing 00000000.tx.19: The expression of this enzyme is affected by cholesterol, insulin, thyroid hormone, bile acids, fasting, and refeeding and also varies diurnally (5). 

Phrase: "The expression of this enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "affected by cholesterol,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "thyroid hormone,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0040135:Thyroid hormone [Amino Acid, Peptide, or Protein,Hormone]
   861   C0019932:Hormone [Hormone]
   861   C0040132:Thyroid, NOS [Body Part, Organ, or Organ Component]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "bile acids,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0005390:Bile Acids [Biologically Active Substance,Steroid]
  1000   C0523530:Bile Acids [Laboratory Procedure]
   966 E C2917673:Bile Acid [Pharmacologic Substance]
   955 E C0376167:Choleic Acid [Biologically Active Substance,Pharmacologic Substance,Steroid]
   861   C0001128:Acids [Chemical]
   861   C0005388:Bile [Body Substance]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "refeeding"

Phrase: "and"

Phrase: "also"

Phrase: "varies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548673:Varies [Intellectual Product]

Phrase: "diurnally"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.20: HMG-CoA reductase (HMGR) protein and mRNA levels are both decreased in diabetic animals and can be rapidly restored with insulin treatment (6), suggesting regulation at the transcriptional level. 

Phrase: "HMG-CoA reductase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415615:HMG-CoA REDUCTASE [Gene or Genome]
   901   C0047420:HMG-CoA [Biologically Active Substance,Organic Chemical]
   827   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(HMGR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "both"

Phrase: "decreased in diabetic animals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0003062:Animals [Animal]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "restored with insulin treatment"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "regulation at the transcriptional level."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1158770:Transcriptional Regulation [Genetic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.21: Previous experiments in H4IIE cells (rat hepatoma) showed that the proximal reductase promoter could be activated by insulin (7), at levels greater than or equal to those seen in live animals. 

Phrase: "Previous experiments in H4IIE cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "(rat hepatoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023903:Hepatoma [Neoplastic Process]
   861   C2239176:Hepatoma [Neoplastic Process]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the proximal reductase promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "could"

Phrase: "be"

Phrase: "activated by insulin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "at levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "greater than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439093:Greater Than [Quantitative Concept]
   833   C0443228:greater [Quantitative Concept]
   833   C1704243:Greater [Quantitative Concept]
   799 E C0549177:Great [Quantitative Concept]

Phrase: "or"

Phrase: "equal to those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0205163:Equal To [Qualitative Concept]
           Equal
   790   C1549782:Equal [Idea or Concept]

Phrase: "seen in live animals."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0003062:Animals [Animal]
   770   C0205397:Seen [Qualitative Concept]
   770   C1548795:Live [Qualitative Concept]
   770   C1634625:% live [Qualitative Concept]
   770   C2982691:Live [Activity]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
Processing 00000000.tx.22: Questions remain as to whether this mode of insulin activation mirrors the physiological regulation of the gene. 

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522634:Question [Intellectual Product]

Phrase: "remain as to"

Phrase: "whether"

Phrase: "this mode of insulin activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1513371:Mode [Functional Concept]
   760   C1705738:Mode [Quantitative Concept]
   760   C2347637:Mode [Quantitative Concept]
   760   C2348146:Mode [Quantitative Concept]

Phrase: "mirrors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181868:Mirror [Manufactured Object]
  1000   C1706183:Mirror [Manufactured Object]

Phrase: "the physiological regulation of the gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0017263:Gene Regulation [Genetic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.23: The hamster HMG-CoA reductase gene requires about 300 bp of sequence upstream of the transcription start site for high level expression (8). 

Phrase: "The hamster HMG-CoA reductase gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0017337:Gene [Gene or Genome]
   717   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415615:HMG-CoA REDUCTASE [Gene or Genome]

Phrase: "requires about 300 bp of sequence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "upstream of the transcription start site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0949639:Transcription Start Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0040649:Transcription [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C0439659:Start [Temporal Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "for high level expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.24: This proximal promoter was found to contain sequences sufficient for sterol regulation in cultured cells (9) and shares about 90% sequence identity with the rat promoter (GenBankTM accession number S78687 (10)). 

Phrase: "This proximal promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "sufficient for sterol regulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205410:Sufficient [Qualitative Concept]

Phrase: "in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "(9"

Phrase: ")"

Phrase: "and"

Phrase: "shares about 90% sequence identity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0237876:Share [Social Behavior]
   760   C0424215:Identity [Mental Process]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C1519249:Sequence [Functional Concept]
   760   C2003939:Identity [Finding]

Phrase: "with the rat promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(GenBankTM accession number S78687"

Phrase: "(10"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.25: The HMGR promoter contains a sterol-response element (SRE) that can be activated by SREBP-1 and SREBP-2 in cultured cells and in transgenic mice overexpressing these proteins (1113). 

Phrase: "The HMGR promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a sterol-response element (SRE)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "activated by SREBP-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0217529:SREBP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "SREBP-2 in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0007600:cultured cells [Cell]
   806   C0007635:Cultured Cells [Cell]
   806   C3282338:Cells, Cultured [Cell]
   781 E C0007585:cells culture [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "and in transgenic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1515981:And [Idea or Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1113"

Phrase: ")."
Processing 00000000.tx.26: Although SREBP-1c appears to be insulin-responsive at the mRNA level, recent evidence suggests this factor is more closely tied to lipogenesis than cholesterol biosynthesis (1416). 

Phrase: "Although"

Phrase: "SREBP-1c"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0537474:SREBP-1c [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420398:SREBP-1c [Gene or Genome]
  1000   C3538602:SREBP-1c [Gene or Genome]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "insulin-responsive at the mRNA level,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205342:Responsive [Functional Concept]

Phrase: "recent evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "this factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "more closely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "tied to lipogenesis"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0596843:lipogenesis [Molecular Function]
   790   C1416505:TIED [Gene or Genome]
   790   C1563744:Lipogenesis [Organism Function]
   756 E C0453920:Tie [Manufactured Object]
   756 E C3472712:Tie [Manufactured Object]

Phrase: "than cholesterol biosynthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599474:cholesterol biosynthesis [Molecular Function]
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]

Phrase: "(1416"

Phrase: ")."
Processing 00000000.tx.27: SREBP-2 is a potent activator of the HMG-CoA reductase gene, but insulin regulation of this protein has not been reported. 

Phrase: "SREBP-2"

Phrase: "is"

Phrase: "a potent activator of the HMG-CoA reductase gene,"

Phrase: "but"

Phrase: "insulin regulation of this protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.28: There are several other important elements in the HMG-CoA reductase promoter. 

Phrase: "There"

Phrase: "are"

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other important elements in the HMG-CoA reductase promoter."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C2924497:Other elements [Laboratory Procedure]
   742   C0013879:Elements [Element, Ion, or Isotope]
   708 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.29: These include possible binding sites for Sp1 and NF-Y, as well as a functional cyclic AMP-response element (CRE) (10). 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "possible binding sites for Sp1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0005456:Binding Sites [Receptor]
   773 E C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Sites [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "NF-Y,"

Phrase: "as well as"

Phrase: "a functional cyclic AMP-response element (CRE)"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   937   C1511573:Cyclic AMP Response Element [Gene or Genome]
   840   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0439596:Cyclic [Temporal Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1511572:Cyclic [Temporal Concept]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]
   733 E C0031084:Cyclicities [Temporal Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.30: The CRE in particular was shown to be required for insulin activation of the HMGR promoter in rat hepatoma cells (7). 

Phrase: "The CRE in particular"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C1511573:Cyclic AMP Response Element [Gene or Genome]
   778   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   778   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0439596:Cyclic [Temporal Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1511572:Cyclic [Temporal Concept]
   748   C1704632:Response [Finding]
   748   C1705248:Element [Conceptual Entity]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "required for insulin activation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1514873:Required [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1879547:Activation [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "of the HMGR promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in rat hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0677626:hepatoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0023903:Hepatoma [Neoplastic Process]
   827   C2239176:Hepatoma [Neoplastic Process]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.31: Because of the problems inherent in a cell culture model, especially for a gene that is sterol-sensitive, we decided to perform in vivo footprinting in rat liver. 

Phrase: "Because of the problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1546466:Problems [Idea or Concept]
   966 E C0033213:Problem [Finding]

Phrase: "inherent in a cell culture model,"

Phrase: "especially for a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Gene [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "sterol-sensitive,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "we"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "in vivo footprinting in rat liver."
Processing 00000000.tx.32: This approach allows for a complete unbiased survey of the HMGR promoter. 

Phrase: "This approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "allows for a complete unbiased survey"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0038951:Survey [Intellectual Product]
   753   C0205197:Complete [Qualitative Concept]
   753   C0683607:allow [Social Behavior]
   753   C0725685:COMPLEAT [Food]

Phrase: "of the HMGR promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.33: Performing this technique in animals ensures that the footprint reflects physiological regulation of the gene, in the context of the many nutritional and hormonal stimuli that the liver receives. 

Phrase: "Performing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0884358:Perform [Functional Concept]
   966   C2947996:Perform [Pharmacologic Substance]

Phrase: "this technique in animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449851:Technique [Functional Concept]

Phrase: "ensures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the footprint"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "physiological regulation of the gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0017263:Gene Regulation [Genetic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of the"

Phrase: "many nutritional"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521739:Nutritional [Qualitative Concept]
  1000   C2707262:Nutritional [Clinical Attribute]

Phrase: "and"

Phrase: "hormonal stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "that"

Phrase: "the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "receives."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]
Processing 00000000.tx.34: In vivo footprinting has been used successfully to map where transcription factors are bound to DNA in vivo (17, 18). 

Phrase: "In vivo footprinting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "successfully to"

Phrase: "map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "where transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "bound to DNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.35: Previous in vitro footprinting studies of the HMGR promoter were successful in identifying sterol-responsive elements (19). 

Phrase: "Previous in vitro footprinting studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   872   C0681828:in vitro study [Research Activity]
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "of the HMGR promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "successful in identifying sterol-responsive elements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1272703:Successful [Qualitative Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.36: The only previous in vivo footprints of this promoter failed to detect changes in occupancy in response to insulin in HepG2 cells, although a 1.5-fold increase in mRNA was observed (20). 

Phrase: "The only previous in vivo footprints of this promoter"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "changes in occupancy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in HepG2 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "although"

Phrase: "a 1.5-fold increase in mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.37: In this report we show that diabetes alters the occupancy of the HMG-CoA reductase promoter in live animals.  

Phrase: "In this report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the occupancy of the HMG-CoA reductase promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2827063:Occupancy [Qualitative Concept]

Phrase: "in live animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.38: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Animal Care and TreatmentMale Sprague-Dawley rats, 125150 g (Harlan), were allowed free access to Harlan Teklad 22/5 rodent chow and water. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animal Care"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178478:animal care [Occupation or Discipline]
   861   C1947933:Care [Activity]

Phrase: "and"

Phrase: "TreatmentMale Sprague-Dawley rats,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034715:Rats, Sprague-Dawley [Mammal]
   861   C2699239:Sprague-Dawley [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "125150 g (Harlan"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "free access to Harlan Teklad 22/5 rodent chow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0444454:Access [Spatial Concept]
   742   C1554204:access [Idea or Concept]

Phrase: "and"

Phrase: "water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.39: Animals were kept on a reverse cycle lighting system and were sacrificed at 9:0010:00 a.m., when HMG-CoA reductase expression is at its diurnal high. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "kept on a reverse cycle lighting system"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0023693:lighting [Natural Phenomenon or Process]
   748   C0023700:Lighting [Human-caused Phenomenon or Process]
   748   C0449913:System [Functional Concept]
   748   C1511572:Cycle [Temporal Concept]
   748   C1553451:System [Manufactured Object]
   748   C1555029:Reverse [Idea or Concept]
   748   C1704459:System [Medical Device]
   738   C2718082:Light Cycle [Temporal Concept]
   714   C0333118:Keep [Functional Concept]

Phrase: "and"

Phrase: "were"

Phrase: "sacrificed at 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0681205:Sacrifice [Idea or Concept]

Phrase: ":"

Phrase: "0010"

Phrase: ":"

Phrase: "00 a.m.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "when"

Phrase: "HMG-CoA reductase expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415615:HMG-CoA REDUCTASE [Gene or Genome]

Phrase: "is at its diurnal high."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205250:High [Qualitative Concept]
   760   C0332169:Diurnal [Temporal Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.40: Animals were rendered diabetic by a single subcutaneous injection of streptozotocin (Sigma), 65 mg/kg. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "rendered"

Phrase: "diabetic by a single subcutaneous injection of streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0241863:DIABETIC [Finding]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "65 mg/kg."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439272:mg kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.41: Diabetes was verified by the presence of urinary glucose using Clinistix from Bayer. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "was"

Phrase: "verified by the presence of urinary glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0042027:Urinary [Body Part, Organ, or Organ Component]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1524119:urinary [Qualitative Concept]
   748   C1711411:Verified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Clinistix from Bayer."
Processing 00000000.tx.42: Where indicated, animals were injected subcutaneously with 3.0 units/100 g of recombinant human insulin (Novolin 70/30, Novo Nordisk) 2 h prior to sacrifice. 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "subcutaneously with 3.0 units/100 g of recombinant human insulin"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   756   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   754   C1533581:Recombinant Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Insulin
   738   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   738   C0086418:Human [Human]
   738   C0439148:Units [Quantitative Concept]
   738   C0439267:g% [Quantitative Concept]
   738   C1514798:recombinant [Organism]
   738   C1519795:Units [Quantitative Concept]
   738   C1579433:Insulin [Pharmacologic Substance]
   704 E C1704753:Unit [Manufactured Object]
   704 E C1880519:Unit [Quantitative Concept]

Phrase: "(Novolin 70/30,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0307068:Novolin 70/30 [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0028467:Novolin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "Novo Nordisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331875:Novo Nordisk [Health Care Related Organization]

Phrase: ")"

Phrase: "2 h prior to sacrifice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0011744:2 H [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.43: Nuclei IsolationNuclei were prepared as described previously (21) by centrifugation through dense sucrose. 

Phrase: "Nuclei IsolationNuclei"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(21"

Phrase: ")"

Phrase: "by centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "through dense sucrose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.44: Nuclear Run-on AssayNuclear run-on assays were carried out essentially as described previously (22). 

Phrase: "Nuclear Run-on AssayNuclear run-on assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1519116:Run-On Assays [Molecular Biology Research Technique]
   762   C0005507:Assay [Laboratory Procedure]
   762   C0243073:assay [Qualitative Concept]
   762   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out essentially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.45: After centrifugation, nuclei from 2 g of liver were resuspended in 100 l of PBS with 3 mM MgCl2. 

Phrase: "After centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "nuclei from 2 g of liver"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "resuspended in 100 l of PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1720830:PBS [Disease or Syndrome]
   753   C1823521:PBS [Gene or Genome]

Phrase: "with 3 mM MgCl2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.46: Next, 100 l of 2x run-on buffer (160 mM Tris, pH 7.5, 20 mM MgCl2, 2 mg/ml heparin, 1% Sarkosyl, 0.7 M ammonium sulfate, 0.8 mM each of ATP, GTP, and UTP) and 250 Ci of [-32P]CTP were added to each reaction. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "100 l of 2x run-on buffer"

Phrase: "(160 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "20 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2 mg/ml heparin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "1% Sarkosyl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0074071:sarkosyl [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.7 M ammonium sulfate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0002620:Ammonium Sulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   804   C0002611:Ammonium [Inorganic Chemical]
   804   C0038720:Sulfate [Inorganic Chemical]
   804   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   804   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "0.8 mM"

Phrase: "each of ATP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1457900:Each [Quantitative Concept]

Phrase: "GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "UTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042010:UTP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "and"

Phrase: "250 Ci of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553631:32p [Medical Device]

Phrase: "]CTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010734:CTP [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1420150:CTP [Gene or Genome]

Phrase: "were"

Phrase: "added to each reaction."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.47: Samples were incubated at 37 C to continue extension of RNA transcripts. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated at 37 C to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "continue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "extension of RNA transcripts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231448:Extension [Functional Concept]
   770   C1880641:Extension [Conceptual Entity]
Processing 00000000.tx.48: Samples were then treated with 50 units of DNase I, 40 g of proteinase K and lysed with the addition of 50 l of 10% SDS and 25 l of 0.2 M EDTA. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with 50 units of DNase I,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   778   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
           DNase
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   778   C1148702:DNase I [Genetic Function]
   748   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439148:Units [Quantitative Concept]
   748   C1519795:Units [Quantitative Concept]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1704753:Unit [Manufactured Object]
   714 E C1880519:Unit [Quantitative Concept]

Phrase: "40 g of proteinase K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1955160:40 g [Quantitative Concept]
   760   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "lysed with the addition of 50 l of 10% SDS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0024348:lysed [Pathologic Function]
   739   C1883712:Addition [Functional Concept]

Phrase: "and"

Phrase: "25 l of 0.2 M EDTA."
Processing 00000000.tx.49: After extraction and precipitation, equal counts of 32P-labeled RNA were added to each membrane at 5 x 106 dpm. 

Phrase: "After extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185115:Extraction [Therapeutic or Preventive Procedure]
  1000   C0684295:extraction [Laboratory Procedure]

Phrase: "and"

Phrase: "precipitation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032931:Precipitation [Natural Phenomenon or Process]
  1000   C0032932:Precipitation [Molecular Function]
  1000   C1642401:% precipitation [Quantitative Concept]
  1000   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "equal counts of 32P-labeled RNA"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0439157:counts [Quantitative Concept]
   719 E C0750480:Count [Activity]
   719 E C1705566:Count [Quantitative Concept]

Phrase: "were"

Phrase: "added to each membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0025255:Membrane [Tissue]
   770   C0596901:Membrane [Cell Component]
   770   C1524062:Added [Functional Concept]
   770   C1706182:Membrane [Manufactured Object]
   737 E C1883712:Add [Functional Concept]

Phrase: "at 5 x 106 dpm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1512024:DPM [Intellectual Product]
   812   C1634619:dpm [Quantitative Concept]
Processing 00000000.tx.50: These membranes were spotted previously with 5 g of cDNA encoding HMG-CoA reductase, catalase, or the pBluescript vector. 

Phrase: "These membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "spotted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0329155:Spot [Fish]
   966   C1427618:SPOT [Gene or Genome]
   966   C1705203:Spot [Conceptual Entity]

Phrase: "previously with 5 g of cDNA encoding HMG-CoA reductase,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   782   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1415615:HMG-CoA REDUCTASE [Gene or Genome]
   760   C0047420:HMG-CoA [Biologically Active Substance,Organic Chemical]
   739   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0439267:g% [Quantitative Concept]
   739   C1547699:Encoding [Idea or Concept]
   739   C2700640:Encoding [Activity]

Phrase: "catalase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "or"

Phrase: "the pBluescript vector."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.51: Hybridizations were performed overnight at 57 C. 

Phrase: "Hybridizations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0020202:Hybridization [Genetic Function]
   966   C1300517:Hybridization [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "overnight at 57 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.52: The next day membranes were washed with 2x SSC, 0.1% SDS at room temperature for 1 min, then 0.2x SSC, 0.1% SDS at 60 C for 30 min, followed by 2x SSC containing 250 g of RNase A at 37 C for 30 min. 

Phrase: "The next day membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "washed with 2x SSC,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "0.1% SDS at room temperature"

Phrase: "for 1 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "then 0.2x SSC,"

Phrase: "0.1% SDS at 60 C"

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by 2x SSC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "250 g of RNase A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C2250251:RNase G [Genetic Function]
   760   C0439267:g% [Quantitative Concept]

Phrase: "at 37 C"

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.53: Membranes were given a quick final rinse in 2x SSC and dried, followed by exposure to autoradiography film with an enhancing screen at 70 C for 15 days. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "a quick final rinse in 2x SSC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1701810:Rinse [Functional Concept]
   748   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "dried,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]

Phrase: "followed by exposure"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "to autoradiography film"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086296:Film [Manufactured Object]
   861   C1561571:film [Biomedical or Dental Material]
   861   C1561572:film [Substance]

Phrase: "with an enhancing screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220908:screen [Health Care Activity]
   861   C1305399:screen [Functional Concept]
   861   C1705053:Screen [Medical Device]

Phrase: "at 70 C"

Phrase: "for 15 days."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.54: SequencingThe rat HMG-CoA reductase promoter was obtained by PCR of rat liver genomic DNA, using primers to the sequence published previously (10). 

Phrase: "SequencingThe rat HMG-CoA reductase promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "obtained by PCR of rat liver genomic DNA,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   770   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   770   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0017428:Genomic [Gene or Genome]
   744   C0023884:Liver [Body Part, Organ, or Organ Component]
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0677874:pCR [Finding]
   744   C0736268:LIVER [Body Part, Organ, or Organ Component]
   744   C0887950:genomic [Biomedical Occupation or Discipline]
   744   C1278929:Liver [Body Part, Organ, or Organ Component]
   744   C1301820:Obtained [Functional Concept]
   744   C2346688:LIVER [Food]
   711 E C1706701:Obtain [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers to the sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "previously"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.55: PCR products were sequenced by Retrogen (San Diego). 

Phrase: "PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "sequenced by Retrogen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0004793:Sequence [Nucleotide Sequence]
   756   C0162326:Sequence [Nucleotide Sequence]
   756   C0162327:Sequence [Nucleotide Sequence]
   756   C1519249:Sequence [Functional Concept]

Phrase: "(San Diego"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.56: In Vivo Footprinting of Rat LiverRat liver (2.2g) was minced in 8 ml of ice-cold PBS. 

Phrase: "In Vivo Footprinting of Rat LiverRat liver"

Phrase: "(2.2g"

Phrase: ")"

Phrase: "was"

Phrase: "minced in 8 ml of ice-cold PBS."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0456963:Ice cold [Qualitative Concept]
   744   C0009264:Cold [Natural Phenomenon or Process]
   744   C0009443:Cold [Disease or Syndrome]
   744   C0020746:Ice [Inorganic Chemical]
   744   C0234192:Cold [Physiologic Function]
   744   C0439526:/mL [Quantitative Concept]
   744   C1720830:PBS [Disease or Syndrome]
   744   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.57: Liver pieces were homogenized 45 times on a drill press with a Teflon pestle in a glass vessel. 

Phrase: "Liver pieces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2982836:Piece [Quantitative Concept]

Phrase: "were"

Phrase: "homogenized"

Phrase: "45 times on a drill press"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "with a Teflon pestle"

Phrase: "in a glass vessel."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0005847:Vessel [Body Part, Organ, or Organ Component]
   861   C1511228:Vessel [Tissue]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.58: A 5-ml portion of filtered homogenate was placed in a 50-ml polypropylene centrifuge tube. 

Phrase: "A 5-ml portion of filtered homogenate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449719:Portion [Spatial Concept]

Phrase: "was"

Phrase: "placed in a 50-ml polypropylene centrifuge tube."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0032582:Polypropylene [Biomedical or Dental Material,Organic Chemical]
   744   C0175730:Tube [Medical Device]
   744   C0179834:centrifuge [Medical Device]
   744   C0439526:/mL [Quantitative Concept]
   744   C1547937:Tube NOS [Intellectual Product]
   744   C1561954:tube [Conceptual Entity]
   744   C1704730:TUBE [Medical Device]
   711   C0442504:Place [Spatial Concept]
   711   C1704765:Place [Functional Concept]
   711   C1882509:Place [Activity]
   711   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.59: Each filtered homogenate was treated with 5 l of dimethyl sulfate for 2 min at room temperature. 

Phrase: "Each filtered homogenate"

Phrase: "was"

Phrase: "treated with 5 l of dimethyl sulfate"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0058229:Dimethylsulfate [Hazardous or Poisonous Substance,Organic Chemical]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0038720:Sulfate [Inorganic Chemical]
   748   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   748   C1522326:Treated [Functional Concept]
   748   C3536965:SULFATE [Element, Ion, or Isotope]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "for 2 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.60: The DMS reaction was slowed by rapid dilution with 40 ml of ice-cold PBS. 

Phrase: "The DMS reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "slowed by rapid dilution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0079240:Dilution [Laboratory Procedure]
   770   C0439831:Rapid [Qualitative Concept]
   770   C1948037:Dilution [Functional Concept]
   737   C0439834:Slow [Qualitative Concept]

Phrase: "with 40 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of ice-cold PBS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1720830:PBS [Disease or Syndrome]
   827   C1823521:PBS [Gene or Genome]
   734   C0456963:Ice cold [Qualitative Concept]
Processing 00000000.tx.61: Tubes were centrifuged at 1000 x g for 5 min at 4 C. 

Phrase: "Tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0175730:tubes [Medical Device]
  1000   C1547937:Tubes [Intellectual Product]
  1000   C1704474:Tubes [Quantitative Concept]
   966 E C1561954:tube [Conceptual Entity]
   966 E C1704730:TUBE [Medical Device]

Phrase: "were"

Phrase: "centrifuged at 1000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.62: Pellets were resuspended in 20 ml of PBS and washed again. 

Phrase: "Pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in 20 ml of PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439526:/mL [Quantitative Concept]
   753   C1720830:PBS [Disease or Syndrome]
   753   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "again."
Processing 00000000.tx.63: The pellet was then resuspended in 15 ml of lysis buffer (60 mM Tris, pH 7.5, 100 mM EDTA, 0.5% SDS, and 100 g/ml proteinase K). 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resuspended in 15 ml of lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0024348:Lysis [Pathologic Function]
   748   C0439526:/mL [Quantitative Concept]
   748   C1536403:lysis [Cell Function]

Phrase: "(60 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.5% SDS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "100 g/ml proteinase K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1622131:proteinase [Molecular Function]
   804   C1708601:K' [Quantitative Concept]
   804   C1947941:Proteinase [Enzyme]

Phrase: ")."
Processing 00000000.tx.64: Samples were rocked gently at room temperature for 3 h to completely lyse nuclei. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "rocked"

Phrase: "gently at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1547703:Room [Spatial Concept]
   770   C1638411:Gently [Qualitative Concept]

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "to completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "lyse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lyse [Pathologic Function]

Phrase: "nuclei."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.65: Genomic DNA isolation and piperidine treatment were performed as described previously (17). 

Phrase: "Genomic DNA isolation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0204727:Isolation [Therapeutic or Preventive Procedure]
   827   C0205409:Isolation [Functional Concept]
   827   C0220862:isolation [Laboratory Procedure]
   755 E C1548221:Isolated [Idea or Concept]
   734   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "piperidine treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.66: Roughly 200300 g of DNA was obtained per sample. 

Phrase: "Roughly 200300 g of DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "obtained per sample."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   858   C1277697:Sample obtained [Finding]
   790   C0370003:Sample [Substance]
   790   C1301820:Obtained [Functional Concept]
   790   C2347026:Sample [Conceptual Entity]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.67: Ligation-mediated PCRLigation-mediated PCR was performed according to the original method (17). 

Phrase: "Ligation-mediated PCRLigation-mediated PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed according to the original method"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0025663:Method [Intellectual Product]
   753   C0205313:Original [Idea or Concept]
   753   C0449851:Method [Functional Concept]
   753   C0680240:according [Social Behavior]
   753   C0871511:METHOD [Intellectual Product]
   753   C0884358:Performed [Functional Concept]
   753   C2347409:Original [Occupational Activity]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.68: The primers corresponding to the coding (top) strand of the HMGR promoter starting at 185 were as follows: primer 1, 5'-CAA TAG GAA GGC CGC GAT GC-3'; 

Phrase: "The primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "corresponding to the coding"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0009219:Coding [Occupational Activity]
   737 E C0805701:Code [Intellectual Product]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "strand of the HMGR promoter starting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0700307:Hydroxy [Inorganic Chemical]
   739   C1704972:Strand [Spatial Concept]
   739   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   706   C0439659:Start [Temporal Concept]

Phrase: "at 185"

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "primer 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5'-CAA TAG GAA GGC CGC GAT GC-3'"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   791   C0037293:Tag [Neoplastic Process]
   791   C0061145:GAT [Amino Acid, Peptide, or Protein]
   791   C0181496:Tag [Manufactured Object]
   791   C0439084:>5 [Quantitative Concept]
   791   C0728893:+5 [Quantitative Concept]
   791   C1414899:GAA [Gene or Genome]
   791   C1415027:Ggc [Gene or Genome]
   791   C1422172:GAT [Gene or Genome]
   791   C1710492:TAG [Gene or Genome]
   791   C1832232:CGC [Disease or Syndrome]
   791   C3537453:GC [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.69: primer 2, 5'-ATG CTG GGA CCC GAC TAG CCA TTG-3'; 

Phrase: "primer 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5'-ATG CTG GGA CCC GAC TAG CCA TTG-3'"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0037293:Tag [Neoplastic Process]
   790   C0179630:CTG [Medical Device]
   790   C0181496:Tag [Manufactured Object]
   790   C0220668:CCA [Congenital Abnormality]
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]
   790   C1705968:CTG [Quantitative Concept]
   790   C1710492:TAG [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.70: and primer 3, 5'-ATG CTG GGA CCC GAC TAG CCA TTG GTT G-3'. 

Phrase: "and"

Phrase: "primer 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5'-ATG CTG GGA CCC GAC TAG CCA TTG GTT G-3'."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   787   C0037293:Tag [Neoplastic Process]
   787   C0179630:CTG [Medical Device]
   787   C0181496:Tag [Manufactured Object]
   787   C0220668:CCA [Congenital Abnormality]
   787   C0439084:>5 [Quantitative Concept]
   787   C0439267:g% [Quantitative Concept]
   787   C0728893:+5 [Quantitative Concept]
   787   C1705968:CTG [Quantitative Concept]
   787   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.71: The primers to reveal the template (bottom) strand starting at 58 were as follows: primer 1, 5'-CGG AAG GAA CTG CGC TTA CG-3'; 

Phrase: "The primers to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "the template"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0728990:TEMPLATE [Medical Device]
  1000   C1514575:Template [Conceptual Entity]
  1000   C1705542:Template [Idea or Concept]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "strand starting at 58"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0439659:Start [Temporal Concept]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "primer 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5'-CGG AAG GAA CTG CGC TTA CG-3'"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   791   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0179630:CTG [Medical Device]
   791   C0439084:>5 [Quantitative Concept]
   791   C0728893:+5 [Quantitative Concept]
   791   C0796552:AAG [Antibiotic,Organic Chemical]
   791   C1414899:GAA [Gene or Genome]
   791   C1417239:AAG [Gene or Genome]
   791   C1627773:TTA [Finding]
   791   C1705968:CTG [Quantitative Concept]
   791   C1832232:CGC [Disease or Syndrome]
   791   C1864172:CGG [Disease or Syndrome]
   791   C2986643:AAG [Gene or Genome]
   791   C3540479:CG [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.72: primer 2, 5'-AAC CGG CCG CCA ATA AGG AAG GAT C-3'; 

Phrase: "primer 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5'-AAC CGG CCG CCA ATA AGG AAG GAT C-3'"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   788   C0061145:GAT [Amino Acid, Peptide, or Protein]
   788   C0220668:CCA [Congenital Abnormality]
   788   C0439084:>5 [Quantitative Concept]
   788   C0728893:+5 [Quantitative Concept]
   788   C0796552:AAG [Antibiotic,Organic Chemical]
   788   C1417239:AAG [Gene or Genome]
   788   C1422172:GAT [Gene or Genome]
   788   C1516476:CCG [Health Care Related Organization]
   788   C1864172:CGG [Disease or Syndrome]
   788   C2986643:AAG [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.73: and primer 3, 5'-CGG CCG CCA ATA AGG AAG GAT CGT CCG ATC-3'. 

Phrase: "and"

Phrase: "primer 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5'-CGG CCG CCA ATA AGG AAG GAT CGT CCG ATC-3'."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   787   C0061145:GAT [Amino Acid, Peptide, or Protein]
   787   C0220668:CCA [Congenital Abnormality]
   787   C0439084:>5 [Quantitative Concept]
   787   C0728893:+5 [Quantitative Concept]
   787   C0796552:AAG [Antibiotic,Organic Chemical]
   787   C1417239:AAG [Gene or Genome]
   787   C1422172:GAT [Gene or Genome]
   787   C1516476:CCG [Health Care Related Organization]
   787   C1864172:CGG [Disease or Syndrome]
   787   C2986643:AAG [Gene or Genome]
Processing 00000000.tx.74: The following annealing temperatures were used for both primer sets: 58, 63, and 68 C. 

Phrase: "The following annealing temperatures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0039476:Temperatures [Quantitative Concept]
   793 E C0005903:temperature [Organism Attribute]

Phrase: "were"

Phrase: "used for both primer sets"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0036849:Set [Mental Process]
   760   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1273517:used [Finding]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "58,"

Phrase: "63,"

Phrase: "and"

Phrase: "68 C."
Processing 00000000.tx.75: All primers were ordered PAGE-purified from Integrated DNA Technologies. 

Phrase: "All primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "ordered"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1705176:Ordered [Qualitative Concept]
  1000   C1705178:Ordered [Activity]
   966 E C1705175:Order [Intellectual Product]
   966 E C1705177:Order [Classification]
   966 E C1882348:Order [Qualitative Concept]

Phrase: "PAGE-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "purified from Integrated DNA Technologies."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1158478:DNA Integration [Genetic Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0039421:technologies [Occupation or Discipline]
   760   C1998793:Purified [Functional Concept]
Processing 00000000.tx.76: Products were resolved on a 6% polyacrylamide wedge gel with 7.75 M urea. 

Phrase: "Products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "resolved on a 6% polyacrylamide wedge gel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C0439639:Wedge [Spatial Concept]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]

Phrase: "with 7.75 M urea."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   756 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.77: Each PCR used 69 g of DNA. 

Phrase: "Each PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "69 g of DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.78: Nuclear ExtractNuclei isolated from 2 g of rat liver were resuspended in 1 ml of PBS containing 3 mM MgCl2 and were centrifuged at 3000 x g for 5 min at 4 C. 

Phrase: "Nuclear ExtractNuclei"

Phrase: "isolated from 2 g of rat liver"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   748   C0023884:Liver [Body Part, Organ, or Organ Component]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0205409:Isolated [Functional Concept]
   748   C0439267:g% [Quantitative Concept]
   748   C0736268:LIVER [Body Part, Organ, or Organ Component]
   748   C1278929:Liver [Body Part, Organ, or Organ Component]
   748   C1548221:Isolated [Idea or Concept]
   748   C2346688:LIVER [Food]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "resuspended in 1 ml of PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439526:/mL [Quantitative Concept]
   753   C1720830:PBS [Disease or Syndrome]
   753   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "3 mM MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "were"

Phrase: "centrifuged at 3000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.79: Nuclear pellets were resuspended in 0.51.0 ml of high salt buffer (420 mM NaCl, 20 mM HEPES, pH 7.9, 1 mM EDTA, 1 mM EGTA, 20% glycerol, 20 mM NaF, 1 mM Na3VO4, 1 mM Na4P2O7, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 1x protease inhibitor mixture; Sigma). 

Phrase: "Nuclear pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in 0.51.0 ml of high salt buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0036140:Salt [Chemical Viewed Structurally]
   739   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   739   C0205250:High [Qualitative Concept]
   739   C0206136:Salt [Food,Inorganic Chemical]
   739   C0439526:/mL [Quantitative Concept]
   739   C1299351:High [Qualitative Concept]
   739   C2700149:HIGH [Intellectual Product]

Phrase: "(420 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "20 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "20% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "20 mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: "1 mM Na3VO4,"

Phrase: "1 mM Na4P2O7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0663811:Na4P2O7 [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "0.5 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1x protease inhibitor mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439962:Mixture [Substance]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.80: Nuclei were lysed by rotating slowly at 4 C for 30 min. 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "lysed by rotating slowly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0024348:lysed [Pathologic Function]
   770   C0231458:rotating [Spatial Concept]
   770   C0439834:Slowly [Qualitative Concept]

Phrase: "at 4 C"

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.81: The lysates were then centrifuged at 15,700 x g for 15 min to pellet nuclear debris. 

Phrase: "The lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged at 15,700 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "to pellet nuclear debris."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0440266:Debris [Substance]
Processing 00000000.tx.82: The supernatant (nuclear extract) was collected and stored at 70 C until needed. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "(nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   861   C2828366:Extract [Substance]

Phrase: ")"

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "stored at 70 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]

Phrase: "until"

Phrase: "needed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]
Processing 00000000.tx.83: Protein concentrations were determined using the BCA assay (Pierce). 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BCA assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "(Pierce"

Phrase: ")."
Processing 00000000.tx.84: EMSAElectrophoretic mobility shift assays were performed as described previously (23). 

Phrase: "EMSAElectrophoretic mobility shift assays"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0949632:Mobility Shift Assays [Laboratory Procedure]
   812   C0333051:Shift [Functional Concept]
   812   C0425245:Mobility [Finding]
   812   C0449580:Mobility [Qualitative Concept]
   812   C2347509:Shift [Phenomenon or Process]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]
   741 E C0231435:Mobile [Functional Concept]
   741 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.85: Briefly, probes corresponding to the HMG-CoA reductase promoter footprinted regions were generated by annealing two complementary oligonucleotides (Integrated DNA Technologies, Inc.). 

Phrase: "Briefly,"

Phrase: "probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "corresponding to the HMG-CoA reductase promoter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415615:HMG-CoA REDUCTASE [Gene or Genome]
   778   C0047420:HMG-CoA [Biologically Active Substance,Organic Chemical]
   748   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "footprinted"

Phrase: "regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "were"

Phrase: "generated by annealing two complementary oligonucleotides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205448:Two [Quantitative Concept]
   753   C3146294:Generated [Activity]

Phrase: "(Integrated DNA Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.86: The sequences are as follows: 59/82, 5'-CAG CCT CCC GCC GAT TGG CTA GGG-3' and 5'-CTG ACC CTA GCC AAT CGG CGG GAG GCT G-3'; 

Phrase: "The sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "59/82,"

Phrase: "5'-CAG CCT CCC GCC GAT TGG CTA GGG-3'"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0061145:GAT [Amino Acid, Peptide, or Protein]
   790   C0266539:CCT [Congenital Abnormality,Disease or Syndrome]
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]
   790   C1422172:GAT [Gene or Genome]
   790   C3540513:CTA [Gene or Genome]

Phrase: "and"

Phrase: "5'-CTG ACC CTA GCC AAT CGG CGG GAG GCT G-3'"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   787   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
   787   C0179630:CTG [Medical Device]
   787   C0282160:ACC [Congenital Abnormality]
   787   C0439084:>5 [Quantitative Concept]
   787   C0439267:g% [Quantitative Concept]
   787   C0728893:+5 [Quantitative Concept]
   787   C1705968:CTG [Quantitative Concept]
   787   C1864172:CGG [Disease or Syndrome]
   787   C3537219:AAT [Gene or Genome]
   787   C3538813:GCT [Gene or Genome]
   787   C3540513:CTA [Gene or Genome]
   787   C3541413:ACC [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.87: 115/85, 5'GCG ACC GTT CGT GAC GTA GGC CGT CAG GCT-3' and 5'-AGC CTG ACG GCC TAC GTC ACG AAA CGG T-3'; 

Phrase: "115/85,"

Phrase: "5'GCG ACC GTT CGT GAC GTA GGC CGT CAG GCT-3'"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   787   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
   787   C0282160:ACC [Congenital Abnormality]
   787   C0439084:>5 [Quantitative Concept]
   787   C0728893:+5 [Quantitative Concept]
   787   C1415027:Ggc [Gene or Genome]
   787   C2697657:GTA [Gene or Genome]
   787   C3538813:GCT [Gene or Genome]
   787   C3541413:ACC [Gene or Genome]

Phrase: "and"

Phrase: "5'-AGC CTG ACG GCC TAC GTC ACG AAA CGG T-3'"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   787   C0050397:AcG [Amino Acid, Peptide, or Protein]
   787   C0179630:CTG [Medical Device]
   787   C0439084:>5 [Quantitative Concept]
   787   C0728893:+5 [Quantitative Concept]
   787   C1428097:ACG [Gene or Genome]
   787   C1455888:AGC [Cell]
   787   C1705968:CTG [Quantitative Concept]
   787   C1864172:CGG [Disease or Syndrome]
   787   C1883257:TAC [Therapeutic or Preventive Procedure]
   787   C2962221:TAC [Pharmacologic Substance]
   787   C2986848:TAC [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.88: 119/142, 5-GGG TGC GAG CAG TGG GCG GTT GTT-3' and 5'-CTG AAA CAA CCG CCC ACT GCT CGC ACC C-3'; 

Phrase: "119/142,"

Phrase: "5-GGG TGC GAG CAG TGG GCG GTT GTT-3'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]
   790   C1420714:TGC [Gene or Genome]

Phrase: "and"

Phrase: "5'-CTG AAA CAA CCG CCC"

Phrase: "ACT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "GCT CGC ACC C-3'"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0101856:Acc-C [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
   804   C0282160:ACC [Congenital Abnormality]
   804   C1832232:CGC [Disease or Syndrome]
   804   C3538813:GCT [Gene or Genome]
   804   C3541413:ACC [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.89: and 129/152, 5'-TTC TCC GCC CGG GTG CGA GCA GTG-3' and 5'-CTG ACA CTG CTC GCA CCC GGG CGG AGA A-3'. 

Phrase: "and"

Phrase: "129/152,"

Phrase: "5'-TTC TCC GCC CGG GTG CGA GCA GTG-3'"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0077072:TCC [Organic Chemical,Pharmacologic Substance]
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]
   790   C1167383:TCC [Cell Component]
   790   C1861305:TCC [Disease or Syndrome]
   790   C1864172:CGG [Disease or Syndrome]
   790   C3539168:CGA [Disease or Syndrome]

Phrase: "and"

Phrase: "5'-CTG ACA CTG CTC GCA CCC GGG CGG AGA A-3'."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   787   C0149561:ACA [Body Part, Organ, or Organ Component]
   787   C0179630:CTG [Medical Device]
   787   C0439084:>5 [Quantitative Concept]
   787   C0728893:+5 [Quantitative Concept]
   787   C1705968:CTG [Quantitative Concept]
   787   C1864172:CGG [Disease or Syndrome]
Processing 00000000.tx.90: One pmol of probe was labeled by the Klenow fill in reaction using 20 Ci of [-32P]dCTP, along with cold 0.125 mM dATP, dGTP, and dTTP. 

Phrase: "One pmol of probe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439192:pmol [Quantitative Concept]

Phrase: "was"

Phrase: "labeled by the Klenow fill in reaction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C3273494:Fill In [Activity]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1708059:Fill [Activity]
   748   C1708632:Labeled [Qualitative Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "20 Ci of [-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553631:32p [Medical Device]

Phrase: "]dCTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "along with cold 0.125 mM dATP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0045186:dATP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "dGTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057430:dGTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "dTTP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076582:dTTP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.91: Each probe (25 fmol) was incubated with 10 g of rat liver nuclear extract in a binding buffer (10 mM HEPES, pH 7.9, 25 mM KCl, 0.5 mM EDTA, 50 g/ml poly(dI-dC), 5% glycerol, 0.5 mM dithiothreitol, 125 g/ml bovine serum albumin) for 20 min at room temperature. 

Phrase: "Each probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "(25 fmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439195:fmol [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with 10 g of rat liver nuclear extract"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C1518434:Nuclear Extract [Biomedical or Dental Material]
   764   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   762   C0023899:Liver Extract [Organic Chemical,Pharmacologic Substance]
   742   C0023884:Liver [Body Part, Organ, or Organ Component]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0439267:g% [Quantitative Concept]
   742   C0521447:Nuclear [Spatial Concept]
   742   C0736268:LIVER [Body Part, Organ, or Organ Component]
   742   C1278929:Liver [Body Part, Organ, or Organ Component]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C2346688:LIVER [Food]
   742   C2828366:Extract [Substance]

Phrase: "in a binding buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(10 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "25 mM KCl,"

Phrase: "0.5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "50 g/ml poly(dI-dC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   839   C0071406:poly dC [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "5% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "0.5 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "125 g/ml bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   827   C0728877:serum albumin [Laboratory or Test Result]
   799   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0007452:Bovine [Mammal]
   799   C0229671:Serum [Body Substance]
   799   C1140701:bovine [Mammal]
   799   C1546774:Serum [Intellectual Product]
   799   C1550100:Serum [Body Substance]

Phrase: ")"

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.92: One to two g of the following antisera were added to the binding reactions: NF-Y (sc-7711x), NF-Y (sc-13045x), NF-1 (sc-870), CREB-1 (sc-187x), Sp1 (sc-59x), and Sp1 (sc-420x) from Santa Cruz Biotechnology. 

Phrase: "One to two g of the following antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "were"

Phrase: "added to the binding reactions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1524062:Added [Functional Concept]
   726   C0443286:Reaction [Functional Concept]
   726   C1114821:Reaction [Clinical Attribute]
   726 E C1883712:Add [Functional Concept]

Phrase: ":"

Phrase: "NF-Y (sc-7711x"

Phrase: ")"

Phrase: ","

Phrase: "NF-Y (sc-13045x"

Phrase: ")"

Phrase: ","

Phrase: "NF-1"

Phrase: "(sc-870"

Phrase: ")"

Phrase: ","

Phrase: "CREB-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1447703:CREB-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(sc-187x"

Phrase: ")"

Phrase: ","

Phrase: "Sp1"

Phrase: "(sc-59x"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Sp1"

Phrase: "(sc-420x"

Phrase: ")"

Phrase: "from Santa Cruz Biotechnology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]
Processing 00000000.tx.93: Binding reactions were run on a 6% polyacrylamide gel in 0.25x TBE. 

Phrase: "Binding reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "a 6% polyacrylamide gel in 0.25x TBE."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C1382104:Gel [Substance]
Processing 00000000.tx.94: Chromatin Preparation from Rat LiverRat liver (2.2 g) was placed in a beaker containing 10 ml of ice-cold PBS. 

Phrase: "Chromatin Preparation from Rat LiverRat liver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0023899:Liver preparation [Organic Chemical,Pharmacologic Substance]
   753   C0455052:Preparation [Health Care Activity]
   753   C1521827:Preparation [Functional Concept]

Phrase: "(2.2 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "placed in a beaker"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 ml of ice-cold PBS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.95: The liver was minced into small pieces and diluted with an equal volume of 2% formaldehyde in PBS followed by a 10-min incubation at room temperature. 

Phrase: "The liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "was"

Phrase: "minced into small pieces"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0700321:Small [Quantitative Concept]
   737   C2982836:Piece [Quantitative Concept]

Phrase: "and"

Phrase: "diluted with an equal volume of 2% formaldehyde"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C0808397:Volume 2 [Quantitative Concept]
   744   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   744   C0205163:Equal [Qualitative Concept]
   744   C0449468:*Volume [Quantitative Concept]
   744   C1549782:Equal [Idea or Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]
   711   C1720119:Dilute [Functional Concept]
   711   C1948037:Dilute [Functional Concept]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "followed by a 10-min incubation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332283:Followed by [Temporal Concept]
           followed
   790   C0456692:/10 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.96: Formaldehyde cross-linking was stopped by the addition of 2 ml of 1.25 M glycine. 

Phrase: "Formaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "stopped by the addition of 2 ml of 1.25 M glycine."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   736   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0439526:/mL [Quantitative Concept]
   736   C0441923:M+ [Intellectual Product]
   736   C0522461:Glycine [Plant]
   736   C1272691:stopped [Qualitative Concept]
   736   C1883712:Addition [Functional Concept]
   703 E C1947925:Stop [Activity]
   703 E C2746065:Stop [Temporal Concept]
Processing 00000000.tx.97: Liver pieces were washed three times with 10 ml of ice-cold PBS. 

Phrase: "Liver pieces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2982836:Piece [Quantitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with 10 ml of ice-cold PBS."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0040223:times [Temporal Concept]
   742   C1632851:Times [Quantitative Concept]
   708 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.98: Samples were then homogenized in 12 ml of nuclei isolation buffer + Triton X-100 using a Teflon glass homogenizer in a drill press. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "homogenized in 12 ml of nuclei isolation buffer + Triton X-100"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   775   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   756   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   738   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   738   C0204727:Isolation [Therapeutic or Preventive Procedure]
   738   C0205409:Isolation [Functional Concept]
   738   C0220862:isolation [Laboratory Procedure]
   738   C0242759:Triton [Geographic Area]
   738   C0439526:/mL [Quantitative Concept]
   737   C3496275:nucleus X [Body Part, Organ, or Organ Component]
   704   C0007610:Nucleus [Cell Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Teflon glass homogenizer in a drill press."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0181200:homogenizer [Medical Device]
Processing 00000000.tx.99: Nuclei were isolated by centrifugation through dense sucrose. 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "isolated by centrifugation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "through dense sucrose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.100: Nuclei were resuspended in 12 ml of PBS containing 3 mM MgCl2 and centrifuged at 3,000 x g for 5 min in 1.5-ml tubes. 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "resuspended in 12 ml of PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439526:/mL [Quantitative Concept]
   753   C1720830:PBS [Disease or Syndrome]
   753   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "3 mM MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "centrifuged at 3,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in 1.5-ml tubes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0175730:tubes [Medical Device]
   812   C1547937:Tubes [Intellectual Product]
   812   C1704474:Tubes [Quantitative Concept]
   779 E C1561954:tube [Conceptual Entity]
   779 E C1704730:TUBE [Medical Device]
Processing 00000000.tx.101: The nuclear pellet occupied an 50-l volume and was white in color. 

Phrase: "The nuclear pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "occupied"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548223:Occupied [Idea or Concept]

Phrase: "an 50-l volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "was"

Phrase: "white in color."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0220938:White color [Qualitative Concept]
           White
   790   C0007457:White [Population Group]
   790   C0043157:White [Population Group]
Processing 00000000.tx.102: Nuclei were then resuspended in 1 ml of nuclei lysis buffer (50 mM Tris, pH 8.1, 10 mM EDTA, 1% SDS, 1 g/ml leupeptin, 1 g/ml aprotinin, and 0.1 M phenylmethylsulfonyl fluoride). 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resuspended in 1 ml of nuclei lysis buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0024348:Lysis [Pathologic Function]
   744   C0439526:/mL [Quantitative Concept]
   744   C1536403:lysis [Cell Function]
   711   C0007610:Nucleus [Cell Component]

Phrase: "(50 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 8.1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1% SDS,"

Phrase: "1 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1 g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1 M phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.103: Sonication was accomplished with a Heat Systems-Ultrasonics W375 sonicater with a microtip. 

Phrase: "Sonication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037680:Sonication [Research Activity]

Phrase: "was"

Phrase: "accomplished with a Heat Systems-Ultrasonics W375 sonicater"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0018837:Heat [Natural Phenomenon or Process]
   744   C1456803:Ultrasonics [Natural Phenomenon or Process]
   711   C0449913:System [Functional Concept]
   711   C1553451:System [Manufactured Object]
   711   C1704459:System [Medical Device]

Phrase: "with a microtip."
Processing 00000000.tx.104: Ten 10-s bursts at a power setting of 4, 40% duty cycle, were sufficient to shear chromatin to an average size of 200600 bp. 

Phrase: "Ten 10-s"

Phrase: "bursts at a power setting of 4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C2924518:Power setting [Finding]
   748   C0032863:Power [Human-caused Phenomenon or Process]
   748   C0439818:burst [Qualitative Concept]
   748   C0542559:setting [Functional Concept]
   748   C1318139:{Setting} [Quantitative Concept]
   748   C1881705:BURST [Phenomenon or Process]

Phrase: "40% duty cycle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "were"

Phrase: "sufficient to shear chromatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205410:Sufficient [Qualitative Concept]

Phrase: "to an average size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "of 200600 bp."
Processing 00000000.tx.105: Shearing of chromatin was checked by electrophoresis on a 3% agarose gel. 

Phrase: "Shearing of chromatin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205013:Shearing [Therapeutic or Preventive Procedure]
   756 E C0175735:shear [Medical Device]

Phrase: "was"

Phrase: "checked by electrophoresis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C1283174:Checked [Activity]

Phrase: "on a 3% agarose gel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1706746:Agarose Gel [Research Device]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]
Processing 00000000.tx.106: Chromatin concentrations were equalized to 0.3 mg/ml by A260 and stored at 70 C until needed. 

Phrase: "Chromatin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "equalized to 0.3 mg/ml"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0439294:mg ml [Quantitative Concept]
   753   C0439269:mg% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "by A260"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706688:A260 [Molecular Biology Research Technique]

Phrase: "and"

Phrase: "stored at 70 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1698986:Store [Functional Concept]

Phrase: "until"

Phrase: "needed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]
Processing 00000000.tx.107: Chromatin Immunoprecipitation AssaysChromatin immunoprecipitations were performed essentially as described previously (24). 

Phrase: "Chromatin Immunoprecipitation AssaysChromatin immunoprecipitations"

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "essentially"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.108: Briefly, chromatin suspensions were diluted 1:10 and pre-cleared with single-stranded DNA/protein A-agarose beads (Upstate). 

Phrase: "Briefly,"

Phrase: "chromatin suspensions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0038960:Suspensions [Biomedical or Dental Material]
   827 E C1382107:Suspension [Substance]
   827 E C1705537:Suspension [Functional Concept]

Phrase: "were"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10"

Phrase: "and"

Phrase: "pre-cleared with single-stranded DNA/protein A-agarose beads"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   782   C0012935:DNA, Single-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   757   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0036681:Agarose [Carbohydrate]
   739   C0037179:Single [Population Group]
   739   C0087136:single [Finding]
   739   C0205171:Single [Quantitative Concept]
   739   C0332152:Pre [Temporal Concept]
   739   C0521097:cleared [Functional Concept]
   739   C0740175:Pre [Qualitative Concept]
   739   C0991566:Beads [Biomedical or Dental Material]
   739   C2257086:PRE [Genetic Function]
   724   C1979975:Single strand [Qualitative Concept]
   706 E C2346972:Bead [Spatial Concept]
   706 E C2963144:Clear [Qualitative Concept]

Phrase: "(Upstate"

Phrase: ")."
Processing 00000000.tx.109: Each immunoprecipitation reaction received 15 g of chromatin and 5 g of the appropriate antibody: USF-2 (sc-862), CREB-1 (sc-187x), and phospho-CREB (sc7978r). 

Phrase: "Each immunoprecipitation reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "15 g of chromatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "5 g of the appropriate antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "USF-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0076925:USF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1706445:USF [Gene or Genome]

Phrase: "(sc-862"

Phrase: ")"

Phrase: ","

Phrase: "CREB-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1447703:CREB-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(sc-187x"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "phospho-CREB"

Phrase: "(sc7978r"

Phrase: ")."
Processing 00000000.tx.110: All antibodies were polyclonal rabbit IgG from Santa Cruz Biotechnology. 

Phrase: "All antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "polyclonal rabbit IgG from Santa Cruz Biotechnology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0034493:Rabbit [Mammal]
Processing 00000000.tx.111: PCR was performed using the following primers (25): HMG-CoA reductase promoter, left 5'-CAA TAG GAA GGC CGC GAT GC-3' and right 5'-CGG AAG GAA CTG CGC TTA CG-3' (58 C); 

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(25"

Phrase: ")"

Phrase: ":"

Phrase: "HMG-CoA reductase promoter,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415615:HMG-CoA REDUCTASE [Gene or Genome]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "5'-CAA TAG GAA GGC CGC GAT GC-3'"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   791   C0037293:Tag [Neoplastic Process]
   791   C0061145:GAT [Amino Acid, Peptide, or Protein]
   791   C0181496:Tag [Manufactured Object]
   791   C0439084:>5 [Quantitative Concept]
   791   C0728893:+5 [Quantitative Concept]
   791   C1414899:GAA [Gene or Genome]
   791   C1415027:Ggc [Gene or Genome]
   791   C1422172:GAT [Gene or Genome]
   791   C1710492:TAG [Gene or Genome]
   791   C1832232:CGC [Disease or Syndrome]
   791   C3537453:GC [Gene or Genome]

Phrase: "and"

Phrase: "right 5'-CGG AAG GAA CTG CGC TTA CG-3'"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0179630:CTG [Medical Device]
   790   C0205090:Right [Spatial Concept]
   790   C0796552:AAG [Antibiotic,Organic Chemical]
   790   C1414899:GAA [Gene or Genome]
   790   C1417239:AAG [Gene or Genome]
   790   C1627773:TTA [Finding]
   790   C1705968:CTG [Quantitative Concept]
   790   C1832232:CGC [Disease or Syndrome]
   790   C1864172:CGG [Disease or Syndrome]
   790   C2986643:AAG [Gene or Genome]
   790   C3540479:CG [Gene or Genome]

Phrase: "(58 C)"

Phrase: ";"
Processing 00000000.tx.112: HMG-CoA reductase Exon 12, left 5'-GGC GGT CAG TGG TAA CTA TT-3' and right 5' GCA GAG CCC ACA AGA TTC TT-3' (57 C). 

Phrase: "HMG-CoA reductase Exon 12,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415615:HMG-CoA REDUCTASE [Gene or Genome]
   840   C0047420:HMG-CoA [Biologically Active Substance,Organic Chemical]
   804   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "5'-GGC GGT CAG TGG TAA CTA TT-3'"

Phrase: "and"

Phrase: "right 5' GCA GAG CCC ACA AGA TTC TT-3'"

Phrase: "(57 C)."
Processing 00000000.tx.113: Plasmid ConstructionA PCR product from rat genomic DNA containing the HMG-CoA reductase promoter from 325 to +70 was cloned into the PGL3 basic vector (Promega) using standard molecular biology techniques. 

Phrase: "Plasmid ConstructionA PCR product from rat genomic DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1514468:product [Entity]
   744   C1704444:Product [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the HMG-CoA reductase promoter from 325 to +70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "cloned into the PGL3 basic vector"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0009013:cloned [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1527178:Basic [Functional Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C1854336:PGL3 [Disease or Syndrome]
   753   C3273620:PGL3 [Gene or Genome]
   719 E C1522642:Clone [Tissue]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard molecular biology techniques."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   906   C1513384:Molecular Biology Technique [Molecular Biology Research Technique]
           Molecular Technique
   812   C0025664:techniques [Intellectual Product]
   812   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.114: Briefly, the 5' primer was designed to possess an overhang to introduce an MluI site by PCR, and the 3' overhang added an XhoI site. 

Phrase: "Briefly,"

Phrase: "the 5' primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "an overhang to"

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "an MluI site by PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "the 3' overhang"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "an XhoI site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.115: The resulting PCR product was digested and cloned into the pGL3 basic backbone. 

Phrase: "The resulting PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "digested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "cloned into the pGL3 basic backbone."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0009013:cloned [Cell]
   753   C0037949:Backbone [Body Part, Organ, or Organ Component]
   753   C1267072:Backbone [Body Part, Organ, or Organ Component]
   753   C1527178:Basic [Functional Concept]
   753   C1854336:PGL3 [Disease or Syndrome]
   753   C3273620:PGL3 [Gene or Genome]
   719 E C1522642:Clone [Tissue]
Processing 00000000.tx.116: Mutant HMGR promoter-luciferase plasmids were generated using the QuikChange kit from Stratagene. 

Phrase: "Mutant HMGR promoter-luciferase plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the QuikChange kit from Stratagene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0812225:KIT [Medical Device]
   760   C1150635:KIT [Molecular Function]
   760   C1705212:Kit [Medical Device]
   760   C1705213:KIT [Medical Device]
   760   C3273202:Kit [Manufactured Object]
Processing 00000000.tx.117: Both mutants were verified by sequencing at the core sequencing facility at the Moffitt Cancer Center, University of South Florida, Tampa, FL. 

Phrase: "Both mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "verified by sequencing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   790   C1711411:Verified [Functional Concept]

Phrase: "at the core sequencing facility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1511521:Core Facility [Health Care Related Organization,Manufactured Object]
   827   C1547538:Facility [Idea or Concept]

Phrase: "at the Moffitt Cancer Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1513817:Cancer Center [Health Care Related Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "University of South Florida,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016253:Florida [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1710133:South [Spatial Concept]

Phrase: "Tampa,"

Phrase: "FL."
Processing 00000000.tx.118: pRL-TK, a vector containing the Renilla luciferase gene driven by the thymidine kinase promoter was from Promega. 

Phrase: "pRL-TK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220928:TK [Geographic Area]

Phrase: "a vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the Renilla luciferase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1334435:Luciferase Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "driven by the thymidine kinase promoter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0040078:Thymidine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   719   C0013126:Drive [Mental Process]

Phrase: "was from Promega."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0072149:Promega [Lipid]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.119: (Primer sequences are available upon request.) 

Phrase: "(Primer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "available upon request."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: ")"
Processing 00000000.tx.120: Cell CultureH4IIE cells (rat hepatoma) were purchased from the American Type Culture Collection. 

Phrase: "Cell CultureH4IIE cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]

Phrase: "(rat hepatoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023903:Hepatoma [Neoplastic Process]
   861   C2239176:Hepatoma [Neoplastic Process]

Phrase: ")"

Phrase: "were"

Phrase: "purchased from the American Type Culture Collection."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C0598079:American Type Culture Collection [Intellectual Product]
   748   C0010453:Culture [Idea or Concept]
   748   C0220814:culture [Functional Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0596070:American [Population Group]
   748   C0869011:purchased [Activity]
   748   C1516698:Collection [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1704814:Collection [Idea or Concept]
   748   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.121: Cells were grown in Eagle's modified essential media supplemented with 10% fetal bovine serum, 100 units of penicillin/streptomycin per ml, and 1 mM sodium pyruvate. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in Eagle's modified essential media"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0009458:Media [Intellectual Product]
   753   C0162867:Media [Tissue]
   753   C0205224:Essential [Qualitative Concept]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C1254021:Media [Tissue]
   753   C1551720:Eagle [Population Group]
   719 E C0439536:Medium [Quantitative Concept]
   719 E C1705217:Medium [Substance]
   719 E C3244283:medium [Intellectual Product]

Phrase: "supplemented with 10% fetal bovine serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "100 units of penicillin/streptomycin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0439148:Units [Quantitative Concept]
   760   C1519795:Units [Quantitative Concept]
   726 E C1704753:Unit [Manufactured Object]
   726 E C1880519:Unit [Quantitative Concept]

Phrase: "per ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "1 mM sodium pyruvate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1576824:Sodium Pyruvate [Organic Chemical,Pharmacologic Substance]
   812   C0034354:pyruvate [Organic Chemical]
   812   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.122: Cells were kept at 37 C and 5% CO2 in a humidified incubator. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "kept at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0333118:Keep [Functional Concept]

Phrase: "and"

Phrase: "5% CO2 in a humidified incubator."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.123: Transient TransfectionsH4IIE cells were plated to an initial density of 100,000 cells per well in 24-well plates the day before the experiment. 

Phrase: "Transient TransfectionsH4IIE cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated to an initial density of 100,000 cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   762   C1441340:100 cells [Cell]
   745   C0017471:initial cell [Cell]
   745   C0162339:Cell Density [Quantitative Concept]
   745   C1166718:cells plate [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0178587:density [Quantitative Concept]
   742   C0205265:Initial [Temporal Concept]
   742   C1279901:Initial [Qualitative Concept]
   742   C1555582:Initial [Idea or Concept]
   742   C1705685:INITIAL [Functional Concept]
   742   C3282337:Cells [Cell]
   708   C0005971:Plate [Medical Device]
   708   C1139930:plate [Medical Device]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   708   C3537155:Plate [Manufactured Object]

Phrase: "per well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "in 24-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "the day before the experiment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]
Processing 00000000.tx.124: The following day, the media were removed, and the cells were washed one time with PBS. 

Phrase: "The following day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "one time with PBS."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C3241998:one time [Intellectual Product]
   770   C0040223:Time [Temporal Concept]
   770   C0205447:One [Quantitative Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.125: Cells were transfected with 1 g of DNA/well using Transfast reagent (Promega) in the recommended 2:1 ratio. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 1 g of DNA/well"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205170:Well [Qualitative Concept]
   748   C0439267:g% [Quantitative Concept]
   748   C3146287:Well [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Transfast reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "in the recommended 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034866:Recommended [Idea or Concept]

Phrase: ":"

Phrase: "1 ratio."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.126: Cells were co-transfected with reporter construct and pRL-TK in a 4:1 ratio. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with reporter construct"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0335038:Reporter [Professional or Occupational Group]
   760   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   760   C1705915:Reporter [Conceptual Entity]
   760   C1709908:Reporter [Group]
   760   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "pRL-TK in a 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0220928:TK [Geographic Area]

Phrase: ":"

Phrase: "1 ratio."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.127: One h after transfection, the 200 l of transfection mix in each well was diluted with 800 l of growth media. 

Phrase: "One h after transfection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "the 200 l of transfection mix"

Phrase: "in each well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "was"

Phrase: "diluted with 800 l of growth media."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   748   C0009458:Media [Intellectual Product]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0162867:Media [Tissue]
   748   C0220844:growth [Physiologic Function]
   748   C1254021:Media [Tissue]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]
   714 E C0439536:Medium [Quantitative Concept]
   714 E C1705217:Medium [Substance]
   714   C1720119:Dilute [Functional Concept]
   714   C1948037:Dilute [Functional Concept]
   714 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.128: 1216 h later, cells were harvested in 100 l of passive lysis buffer and assayed for luciferase activity using the dual luciferase assay kit (Promega). 

Phrase: "1216 h later,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested in 100 l of passive lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0024348:Lysis [Pathologic Function]
   744   C1536403:lysis [Cell Function]
   711   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "assayed for luciferase activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1151115:luciferase activity [Molecular Function]
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the dual luciferase assay kit (Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.129: Data are shown as the average ratio of firefly to Renilla luciferase counts  S.D. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown as the average ratio of firefly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0162328:Firefly [Eukaryote]
   748   C0456603:Ratio [Quantitative Concept]
   748   C1510992:Average [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]
   748   C2825518:AVERAGE [Quantitative Concept]
   714   C1547282:Show [Intellectual Product]

Phrase: "to Renilla luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "counts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439157:counts [Quantitative Concept]
  1000   C0750480:Count [Activity]
  1000   C1705566:Count [Quantitative Concept]

Phrase: "S."

Phrase: "D."
Processing 00000000.tx.130: At least six independent yet identical transfections were performed per condition. 

Phrase: "At least six independent yet identical transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "performed per condition."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0012634:condition [Disease or Syndrome]
   790   C0348080:Condition [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   790   C1705253:Condition [Conceptual Entity]
   756 E C2947996:Perform [Pharmacologic Substance]
   718 E C0009647:Conditioned [Mental Process]
   718 E C1701901:Conditional [Qualitative Concept]
   718 E C1963686:Conditional [Functional Concept]
Processing 00000000.tx.131: All plasmid concentrations were checked by A260 prior to transfection.  

Phrase: "All plasmid concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "checked by A260"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1283174:Checked [Activity]
   790   C1706688:A260 [Molecular Biology Research Technique]

Phrase: "prior to transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.132: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Nuclear run-on assays were performed to determine whether insulin acts to increase transcription of the HMG-CoA reductase gene. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Nuclear run-on assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1519116:Run-On Assays [Molecular Biology Research Technique]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "transcription of the HMG-CoA reductase gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0040649:Gene Transcription [Genetic Function]
           Transcription
Processing 00000000.tx.133: Inbred male Sprague-Dawley rats were injected with streptozotocin (65 mg/kg) to induce diabetes. 

Phrase: "Inbred male Sprague-Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0034715:Rats, Sprague-Dawley [Mammal]
   840   C2699239:Sprague-Dawley [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "injected with streptozotocin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   756   C1720154:Inject [Functional Concept]

Phrase: "(65 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439272:mg kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.134: Animals were sacrificed during the 3rd h of the dark cycle, at the diurnal high for hepatic HMG-CoA reductase expression. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "sacrificed during the 3rd h of the dark cycle,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0205437:3rd [Quantitative Concept]
   742   C0332582:Dark [Qualitative Concept]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]
   742   C1511572:Cycle [Temporal Concept]
   708   C0681205:Sacrifice [Idea or Concept]

Phrase: "at the diurnal high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "for hepatic HMG-CoA reductase expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415615:HMG-CoA REDUCTASE [Gene or Genome]
Processing 00000000.tx.135: Nuclei were isolated from the livers of these animals, and nuclear run-on assays were performed as described under "Materials and Methods." 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "isolated from the livers of these animals,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   748   C0003062:Animals [Animal]
   748   C0023884:Livers [Body Part, Organ, or Organ Component]
   748   C0205409:Isolated [Functional Concept]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   714 E C1278929:Liver [Body Part, Organ, or Organ Component]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
   714 E C2346688:LIVER [Food]

Phrase: "and"

Phrase: "nuclear run-on assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1519116:Run-On Assays [Molecular Biology Research Technique]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.136: HMG-CoA reductase transcription was greatly diminished in the diabetic animals (Fig. 1A). 

Phrase: "HMG-CoA reductase transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0040649:Transcription [Genetic Function]
   756   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415615:HMG-CoA REDUCTASE [Gene or Genome]

Phrase: "was"

Phrase: "greatly"

Phrase: "diminished in the diabetic animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0003062:Animals [Animal]
   760   C0205216:Diminished [Quantitative Concept]
   760   C0241863:DIABETIC [Finding]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.137: It was also found that administration of insulin to diabetic animals restored HMG-CoA reductase transcription to normal in just 2 h (Fig. 1B). 

Phrase: "It"

Phrase: "was"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that administration of insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C0199782:Administration of insulin [Therapeutic or Preventive Procedure]
           administration insulin
   770   C0001554:Administration [Occupational Activity]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "to diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "restored"

Phrase: "HMG-CoA reductase transcription to normal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040649:Transcription [Genetic Function]

Phrase: "in just 2 h (Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.138: We next carried out in vivo footprinting to examine the occupancy of the hepatic HMGR promoter. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "footprinting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the occupancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827063:Occupancy [Qualitative Concept]

Phrase: "of the hepatic HMGR promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.139: Livers from normal and diabetic animals were treated with dimethyl sulfate and subjected to footprinting by ligation-mediated PCR. 

Phrase: "Livers from normal"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   841   C0577059:Liver normal [Finding]
   790   C0023884:Livers [Body Part, Organ, or Organ Component]
   756 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   756 E C1278929:Liver [Body Part, Organ, or Organ Component]
   756 E C2346688:LIVER [Food]
   718 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "treated with dimethyl sulfate"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0058229:Dimethylsulfate [Hazardous or Poisonous Substance,Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0038720:Sulfate [Inorganic Chemical]
   770   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   770   C1522326:Treated [Functional Concept]
   770   C3536965:SULFATE [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "subjected to footprinting"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "by ligation-mediated PCR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
Processing 00000000.tx.140: A primer set designed to reveal the top strand begins by reading cytosines at 185. 

Phrase: "A primer set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "the top strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704972:Strand [Spatial Concept]
   861   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "begins by reading cytosines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034754:Reading [Daily or Recreational Activity]
   770   C0439659:Begin [Temporal Concept]
   770   C1705179:Reading [Finding]
   737   C0010843:Cytosine [Biologically Active Substance,Organic Chemical]

Phrase: "at 185."
Processing 00000000.tx.141: Another primer set reveals the bottom strand by reading guanines beginning at 58. 

Phrase: "Another primer set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "the bottom strand by reading guanines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704972:Strand [Spatial Concept]
   753   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "beginning at 58."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439659:Beginning [Temporal Concept]
Processing 00000000.tx.142: It should be noted that these primers were designed against the rat HMGR promoter sequence, which varies slightly (about 10 bp) from the hamster (10). 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "these primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "against the rat HMGR promoter sequence,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   793   C0004793:Sequence [Nucleotide Sequence]
   793   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0162326:Sequence [Nucleotide Sequence]
   793   C0162327:Sequence [Nucleotide Sequence]
   793   C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "which"

Phrase: "varies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548673:Varies [Intellectual Product]

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "(about 10 bp) from the hamster"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.143: Our primers were designed against sequence from the inbred Sprague-Dawley rats used in our experiments. 

Phrase: "Our primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed against sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0004793:Sequence [Nucleotide Sequence]
   790   C0162326:Sequence [Nucleotide Sequence]
   790   C0162327:Sequence [Nucleotide Sequence]
   790   C1519249:Sequence [Functional Concept]
   756   C1707689:Design [Activity]
   756   C2983265:DESIGN [Intellectual Product]
   718 E C1548958:Sequential [Idea or Concept]
   718 E C1705294:Sequential [Qualitative Concept]

Phrase: "from the inbred Sprague-Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034715:Rats, Sprague-Dawley [Mammal]
   861   C2699239:Sprague-Dawley [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "used in our experiments."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.144: Minor differences from the published rat sequence included an extra G at 15 and a reversal of the CG at 3 and 4. 

Phrase: "Minor differences from the published rat sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "an extra G at 15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "a reversal of the CG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443290:Reversal [Functional Concept]

Phrase: "at 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4."
Processing 00000000.tx.145: Numbering is therefore 1 bp relative to the previously published sequence, based on the transcription start site (Fig. 2). 

Phrase: "Numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbering [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "is"

Phrase: "therefore 1 bp"

Phrase: "relative to the previously published sequence,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "based on the transcription start site"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0949639:Transcription Start Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0040649:Transcription [Genetic Function]
   753   C0205145:Site [Spatial Concept]
   753   C0439659:Start [Temporal Concept]
   753   C1515974:Site [Body Location or Region]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C2825164:Site [Spatial Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.146: On the top strand, several areas of DMS protection or enhancement were detected (Fig. 3). 

Phrase: "On the top strand,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704972:Strand [Spatial Concept]
   861   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "several areas of DMS protection"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "or"

Phrase: "enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1627358:Enhancement [Therapeutic or Preventive Procedure]
  1000   C2349975:Enhancement [Activity]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.147: The Naked lane refers to DNA that was first extracted and purified and then treated with DMS in vitro. 

Phrase: "The Naked lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "refers to DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0205543:refer [Functional Concept]

Phrase: "that"

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with DMS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.148: This lane is a control that shows all the reactive G residues in the sequence. 

Phrase: "This lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "is"

Phrase: "a control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "that"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "all the reactive G residues in the sequence."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.149: Bands that are absent or reduced in intensity in the in vivo samples (Fig. 3, lanes N and D) represent protections where protein binding shields the DNA from dimethyl sulfate attack. 

Phrase: "Bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "that"

Phrase: "are"

Phrase: "absent"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332197:Absent [Quantitative Concept]
  1000   C2699517:ABSENT [Finding]
   928 E C0424530:Absences [Finding]
   928 E C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "reduced in intensity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0392756:Reduced [Qualitative Concept]
   790   C0522510:Intensity [Qualitative Concept]

Phrase: "in the in vivo samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708639:Lane [Spatial Concept]

Phrase: "N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: ")"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "protections where protein binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033618:Protein Binding [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "shields"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183251:Shield [Medical Device]
  1000   C1705198:Shield [Medical Device]

Phrase: "the DNA from dimethyl sulfate attack."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.150: Bands that are significantly darker in the in vivo samples, or new bands that appear in these lanes, are known as enhancements. 

Phrase: "Bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "that"

Phrase: "are"

Phrase: "significantly darker in the in vivo samples,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0332582:Dark [Qualitative Concept]

Phrase: "or"

Phrase: "new bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "that"

Phrase: "appear in these lanes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0700364:APPEAR [Qualitative Concept]
   737   C1708639:Lane [Spatial Concept]

Phrase: "are"

Phrase: "known as enhancements."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205309:Known [Qualitative Concept]
   756   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   756   C2349975:Enhancement [Activity]
Processing 00000000.tx.151: Enhanced DMS reactivity is indicative of protein binding in the nearby area, although generally not on that particular residue. 

Phrase: "Enhanced DMS reactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C0205332:Reactive [Qualitative Concept]

Phrase: "is"

Phrase: "indicative of protein binding"

Phrase: "in the nearby area,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "although"

Phrase: "generally"

Phrase: "not on that particular residue."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1518422:Not [Functional Concept]
   760   C1709915:Residue [Conceptual Entity]
   760   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.152: In Fig. 

Phrase: "In Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.153: 3, the protections are noted with a filled triangle, and enhancements are marked with an open triangle. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "the protections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1545588:Protection [Finding]

Phrase: "are"

Phrase: "noted with a filled triangle,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205119:Triangle [Conceptual Entity]
   760   C1708059:Filled [Activity]
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]

Phrase: "and"

Phrase: "enhancements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   966   C2349975:Enhancement [Activity]

Phrase: "are"

Phrase: "marked with an open triangle."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0175566:Open [Spatial Concept]
   760   C0205119:Triangle [Conceptual Entity]
   760   C0522501:Marked [Qualitative Concept]
   760   C1706089:Marked [Qualitative Concept]
Processing 00000000.tx.154: In both normal and diabetic samples, the CRE was completely protected at 101 and showed enhanced DMS reactivity at 104, 99, and 95/94 (Fig. 3, right). 

Phrase: "In both normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "the CRE"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "protected at 101"

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "enhanced DMS reactivity at 104,"

Phrase: "99,"

Phrase: "and"

Phrase: "95/94"

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.155: This pattern was seen in all animals regardless of treatment. 

Phrase: "This pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "seen in all animals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0003062:Animals [Animal]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "regardless of treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.156: A significant protection seen only in normal animals occurred at 71, as shown in Fig. 

Phrase: "A significant protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "only in normal animals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0003062:Animals [Animal]
   770   C0205171:Only [Quantitative Concept]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "occurred at 71,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0450389:71 [Intellectual Product]
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "as"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.157: 3, right. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "right."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]
Processing 00000000.tx.158: Protections at 137 and 147 were not consistently observed. 

Phrase: "Protections at 137"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1545588:Protection [Finding]

Phrase: "and"

Phrase: "147"

Phrase: "were"

Phrase: "not consistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.159: View larger version (55K): [in this window] [in a new window]  FIGURE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(55K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 1."
Processing 00000000.tx.160: Insulin activates HMG-CoA reductase transcription in diabetic rats. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "HMG-CoA reductase transcription in diabetic rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.161: Nuclei were isolated from normal (N), diabetic (D), or insulin-injected diabetic rats (I). 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "isolated from normal (N), diabetic (D),"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0205307:Normal [Qualitative Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0439166:% normal [Quantitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin-injected diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "(I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.162: Extension of RNA transcripts was carried out with -32P-labeled CTP. 

Phrase: "Extension of RNA transcripts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231448:Extension [Functional Concept]
   770   C1880641:Extension [Conceptual Entity]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with -32P-labeled CTP."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0010734:CTP [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C1420150:CTP [Gene or Genome]
   760   C1553631:32p [Medical Device]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.163: Equal disintegrations/min of RNA were hybridized to membranes containing 5 g of cDNA for HMGR, catalase (CAT), or the pBluescript vector (Blue). 

Phrase: "Equal disintegrations/min of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]

Phrase: "were"

Phrase: "hybridized to membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 g of cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "for HMGR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "catalase (CAT),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "or"

Phrase: "the pBluescript vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "(Blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.164: A, nuclear run-ons from two normal (N1 and N2), and two diabetic rats (D1 and D2). 

Phrase: "A,"

Phrase: "nuclear run-ons from two normal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1518579:ONS [Professional or Occupational Group]

Phrase: "(N1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441962:N1 [Finding]

Phrase: "and"

Phrase: "N2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441960:N2 [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "two diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "(D1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416886:D1 [Gene or Genome]

Phrase: "and"

Phrase: "D2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1414052:D2 [Gene or Genome]
  1000   C1415944:D2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.165: B, nuclear run-ons from four diabetic rats (D14) and four insulin-replenished diabetic rats (I14).  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "nuclear run-ons from four diabetic rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1518579:ONS [Professional or Occupational Group]

Phrase: "(D14"

Phrase: ")"

Phrase: "and"

Phrase: "four insulin-replenished diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
   804   C0241863:DIABETIC [Finding]

Phrase: "(I14"

Phrase: ")."
Processing 00000000.tx.166: On the bottom strand, the CRE is heavily protected at 100, 105, 103, and 109 (Fig. 4, bottom right) in both normal and diabetic animals. 

Phrase: "On the bottom strand,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704972:Strand [Spatial Concept]
   861   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the CRE"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "is"

Phrase: "heavily"

Phrase: "protected at 100,"

Phrase: "105,"

Phrase: "103,"

Phrase: "and"

Phrase: "109"

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "bottom right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "in both normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.167: The A at 102 showed up as an enhancement in both cases. 

Phrase: "The A at 102"

Phrase: "showed up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1547282:Show [Intellectual Product]

Phrase: "as"

Phrase: "an enhancement in both cases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]
Processing 00000000.tx.168: A key difference in the footprints is a very obvious enhancement at 142 seen only in the diabetic samples (Fig. 4, middle right). 

Phrase: "A key difference in the footprints"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "is"

Phrase: "a very obvious enhancement at 142"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "only in the diabetic samples"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205171:Only [Quantitative Concept]
   760   C0241863:DIABETIC [Finding]
   760   C1720467:Only [Intellectual Product]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "middle right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.169: This particularly dark band, indicating enhanced DMS reactivity, was seen in 4/5 diabetic footprints and 0/5 normal footprints. 

Phrase: "This particularly dark band,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "indicating"

Phrase: "enhanced DMS reactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C0205332:Reactive [Qualitative Concept]

Phrase: "was"

Phrase: "seen in 4/5 diabetic footprints"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0205397:Seen [Qualitative Concept]
   753   C0241863:DIABETIC [Finding]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "and"

Phrase: "0/5 normal footprints."
Processing 00000000.tx.170: Conversely, the nearby enhancement at 138 of the normal lane was not seen in diabetic footprints, suggesting possible competition for a binding site in this region. 

Phrase: "Conversely,"

Phrase: "the nearby enhancement at 138 of the normal lane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   742   C2349975:Enhancement [Activity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen in diabetic footprints,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205397:Seen [Qualitative Concept]
   770   C0241863:DIABETIC [Finding]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "possible competition for a binding site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679932:competition [Social Behavior]

Phrase: "in this region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.171: Another obvious difference is an enhancement at 161 in the diabetic lane (Fig. 4, top right). 

Phrase: "Another obvious difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "is"

Phrase: "an enhancement at 161"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "in the diabetic lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "top right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.172: This residue is in the middle of the SRE located between 164 and 155. 

Phrase: "This residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "is in the middle of the SRE"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0013879:Element [Element, Ion, or Isotope]
   742   C0038323:Sterol [Steroid]
   742   C0444598:Middle [Spatial Concept]
   742   C0549183:middle [Spatial Concept]
   742   C0871261:Response [Organism Attribute]
   742   C1552826:middle [Idea or Concept]
   742   C1704632:Response [Finding]
   742   C1705248:Element [Conceptual Entity]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "located between 164"

Phrase: "and"

Phrase: "155."
Processing 00000000.tx.173: The SRE appears unoccupied under normal conditions and enhanced in diabetic samples (4/5 animals). 

Phrase: "The SRE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "unoccupied under normal conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1548224:Unoccupied [Idea or Concept]

Phrase: "and"

Phrase: "enhanced in diabetic samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0241863:DIABETIC [Finding]
   770   C2349975:Enhanced [Activity]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "(4/5 animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003062:Animals [Animal]
   734   C0450367:4 5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.174: Protections at 189/190 were seen in all groups, whereas those at 70 were not observed in the diabetics. 

Phrase: "Protections at 189/190"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1545588:Protection [Finding]

Phrase: "were"

Phrase: "seen in all groups,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0205397:Seen [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "whereas"

Phrase: "those at 70"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in the diabetics."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0241863:diabetics [Finding]
   770   C1441672:Observed [Functional Concept]
Processing 00000000.tx.175: Both of these areas contain potential NF-Y-binding sites, with the sequence ATTGG. 

Phrase: "Both of these areas"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205146:areas [Spatial Concept]
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]
   737 E C0017446:Area [Geographic Area]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "potential NF-Y-binding sites,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0005456:Binding Sites [Receptor]
   806 E C0682969:Binding Site [Amino Acid Sequence]
   804   C0205145:Sites [Spatial Concept]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]

Phrase: "with the sequence ATTGG."
Processing 00000000.tx.176: Because there was an enhancement at 161 of the SRE in four of the five diabetic animals, we wondered if insulin activation could be a result of sterol regulation through the SRE. 

Phrase: "Because"

Phrase: "there"

Phrase: "was"

Phrase: "an enhancement at 161 of the SRE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   742   C2349975:Enhancement [Activity]

Phrase: "in four"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "of the five diabetic animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "we"

Phrase: "wondered"

Phrase: "if"

Phrase: "insulin activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "could"

Phrase: "be"

Phrase: "a result of sterol regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "through the SRE."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.177: To investigate this possibility, we examined livers of rats fed lovastatin or cholesterol to alter liver cholesterol levels. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "livers of rats"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   824   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   790   C0023884:Livers [Body Part, Organ, or Organ Component]
   756 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   756 E C1278929:Liver [Body Part, Organ, or Organ Component]
   756 E C2346688:LIVER [Food]
   718 E C0205054:Hepatic [Body Location or Region]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "lovastatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "cholesterol to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "liver cholesterol levels."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0201950:cholesterol levels [Laboratory Procedure]
   901   C0428466:cholesterol levels [Laboratory or Test Result]
   827   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.178: Animals were fed 0.02% lovastatin or 1% cholesterol for 5 days. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "0.02% lovastatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "1% cholesterol for 5 days."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0008377:Cholesterol [Biologically Active Substance,Steroid]
Processing 00000000.tx.179: Previous research in our lab has shown that a similar dose of lovastatin elevates HMGR transcription 46-fold (22), whereas dietary cholesterol reduces HMGR protein levels to about 1% of control. 

Phrase: "Previous research in our lab"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a similar dose of lovastatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0178602:Dose [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]

Phrase: "elevates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "HMGR transcription 46-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0332462:Fold [Spatial Concept]
   793   C1880834:FOLD [Phenomenon or Process]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "dietary cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008395:Cholesterol, Dietary [Steroid]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "reduces"

Phrase: "HMGR protein levels to about 1%"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   741   C0456947:Level 1 [Intellectual Product]
   741   C0456949:Level 3 [Intellectual Product]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0441889:Levels [Qualitative Concept]
   726   C0428479:Protein level [Laboratory or Test Result]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "of control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.180: It should be noted that dietary cholesterol has only a minor repressive effect on the rate of HMGR transcription in these animals (26). 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that dietary cholesterol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008395:Cholesterol, Dietary [Steroid]
   861   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "has"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a minor repressive effect on the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "of HMGR transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0040649:Transcription [Genetic Function]

Phrase: "in these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.181: We predicted that the lovastatin-fed animals would show strong protections at the SRE, because of elevated cleavage of SREBPs, induced by sterol deprivation. 

Phrase: "We"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "that"

Phrase: "the lovastatin-fed animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "would"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "strong protections at the SRE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1709736:Protection Element [Conceptual Entity]
   714   C1545588:Protection [Finding]

Phrase: "because of elevated cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "of SREBPs,"

Phrase: "induced by sterol deprivation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0038323:Sterol [Steroid]
   770   C0205263:Induced [Functional Concept]
   770   C0871712:Deprivation [Qualitative Concept]
Processing 00000000.tx.182: Curiously, no definitive protections or enhancements at the SRE were visible when animals were fed either lovastatin or cholesterol (Fig. 5, right). 

Phrase: "Curiously,"

Phrase: "no definitive protections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1545588:Protection [Finding]

Phrase: "or"

Phrase: "enhancements at the SRE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   719   C2349975:Enhancement [Activity]

Phrase: "were"

Phrase: "visible"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205379:Visible [Qualitative Concept]

Phrase: "when"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "either lovastatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.183: The footprints were the same for the two animals in each group. 

Phrase: "The footprints"

Phrase: "were"

Phrase: "the same for the two animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0445247:Same [Qualitative Concept]

Phrase: "in each group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.184: The CRE was also heavily protected in these animals but unchanged by either treatment. 

Phrase: "The CRE"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "was"

Phrase: "also heavily"

Phrase: "protected in these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003062:Animals [Animal]

Phrase: "but"

Phrase: "unchanged by either treatment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442739:Unchanged [Finding]
   770   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.185: The enhancement at 138 seen in normal animals was also seen in both lovastatin and cholesterolfed rats. 

Phrase: "The enhancement at 138"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "seen in normal animals"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0003062:Animals [Animal]
   770   C0205307:Normal [Qualitative Concept]
   770   C0205397:Seen [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "was"

Phrase: "also"

Phrase: "seen in both lovastatin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "and"

Phrase: "cholesterolfed rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.186: The enhancement at 142 seen in diabetics was noticeably absent from these animals. 

Phrase: "The enhancement at 142"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "seen in diabetics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C0241863:diabetics [Finding]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "was"

Phrase: "noticeably absent from these animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]
Processing 00000000.tx.187: In addition, the NF-Y sites at 189/190 and 70 are readily visible in this footprint and protected in both cases. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the NF-Y sites at 189/190"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "70"

Phrase: "are"

Phrase: "readily visible in this footprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205379:Visible [Qualitative Concept]

Phrase: "and"

Phrase: "protected in both cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.188: A summary of the major differences between normal and diabetic footprints is presented in Fig. 

Phrase: "A summary of the major differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1552616:summary [Intellectual Product]
   753   C1706244:Summary [Intellectual Product]

Phrase: "between normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic footprints"

Phrase: "is"

Phrase: "presented in Fig."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C0449450:Presented [Idea or Concept]
   790   C1337208:FIG [Food]
   756 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.189: 6. 

Phrase: "6."
Processing 00000000.tx.190: View larger version (11K): [in this window] [in a new window]  FIGURE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 2."
Processing 00000000.tx.191: Partial sequence of the rat HMG-CoA reductase promoter. 

Phrase: "Partial sequence of the rat HMG-CoA reductase promoter."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.192: The rat HMG-CoA reductase promoter was cloned by PCR and sequenced. 

Phrase: "The rat HMG-CoA reductase promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415615:HMG-CoA REDUCTASE [Gene or Genome]

Phrase: "was"

Phrase: "cloned by PCR"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0009013:cloned [Cell]
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   756 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.193: The SRE and CRE are highlighted. 

Phrase: "The SRE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "CRE"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "are"

Phrase: "highlighted."
Processing 00000000.tx.194: The A denotes the transcription start site. 

Phrase: "The A"

Phrase: "denotes"

Phrase: "the transcription start site."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0949639:Transcription Start Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0040649:Transcription [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C0439659:Start [Temporal Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
Processing 00000000.tx.195: Locations of the labeling primers for footprinting are indicated by arrows.  

Phrase: "Locations of the labeling primers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0450429:locations [Spatial Concept]
   726 E C1515974:Location [Body Location or Region]

Phrase: "for footprinting"

Phrase: "are"

Phrase: "indicated by arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.196: View larger version (47K): [in this window] [in a new window]  FIGURE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 3."
Processing 00000000.tx.197: In vivo footprint of the hepatic HMGR promoter, top strand. 

Phrase: "In vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "footprint of the hepatic HMGR promoter,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205054:Hepatic [Body Location or Region]
   739   C0700307:Hydroxy [Inorganic Chemical]

Phrase: "top strand."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704972:Strand [Spatial Concept]
   861   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.198: Livers from normal (N) or diabetic (D) rats were treated with dimethyl sulfate to methylate-exposed guanine residues. 

Phrase: "Livers from normal"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   841   C0577059:Liver normal [Finding]
   790   C0023884:Livers [Body Part, Organ, or Organ Component]
   756 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   756 E C1278929:Liver [Body Part, Organ, or Organ Component]
   756 E C2346688:LIVER [Food]
   718 E C0205054:Hepatic [Body Location or Region]

Phrase: "(N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "(D) rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "treated with dimethyl sulfate to"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0058229:Dimethylsulfate [Hazardous or Poisonous Substance,Organic Chemical]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0038720:Sulfate [Inorganic Chemical]
   760   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   760   C1522326:Treated [Functional Concept]
   760   C3536965:SULFATE [Element, Ion, or Isotope]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "methylate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0746574:methylate [Pharmacologic Substance]

Phrase: "exposed guanine residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.199: DNA was footprinted by ligation-mediated PCR. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "footprinted by ligation-mediated PCR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023690:Ligation [Therapeutic or Preventive Procedure]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0677874:pCR [Finding]
Processing 00000000.tx.200: The Naked lane shows all reactive guanine residues. 

Phrase: "The Naked lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "all reactive guanine residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.201: Protected bases are indicated by a solid triangle, and areas of enhanced DMS reactivity are denoted with an open triangle. 

Phrase: "Protected bases"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   861   C0178499:bases [Chemical Viewed Functionally]
   861   C1626935:Bases [Quantitative Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C1527178:Basis [Functional Concept]
   827 E C1874451:Basis [Pharmacologic Substance]
   827 E C1880279:Base [Biomedical or Dental Material]
   777 E C0205112:Basal [Spatial Concept]
   768 E C0016617:Foundation [Organization]

Phrase: "are"

Phrase: "indicated by a solid triangle,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205119:Triangle [Conceptual Entity]
   760   C0205208:Solid [Qualitative Concept]
   760   C0302909:Solid [Substance]
   760   C1378566:Solid [Biomedical or Dental Material]
   760   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "areas of enhanced DMS reactivity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "are"

Phrase: "denoted with an open triangle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0175566:Open [Spatial Concept]
   760   C0205119:Triangle [Conceptual Entity]
Processing 00000000.tx.202: Because of weak overall signal, the naked lane was given a longer exposure to allow for comparison to the in vivo samples. 

Phrase: "Because of weak overall signal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "the naked lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "was"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "a longer exposure to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0332157:Exposure to [Clinical Attribute]
           Exposure
   827   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "allow for comparison"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0683607:allow [Social Behavior]
   790   C1707455:Comparison [Activity]

Phrase: "to the in vivo samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C1515655:In Vivo [Spatial Concept]
Processing 00000000.tx.203: The 71 region and CRE have been enlarged as shown at right.  

Phrase: "The 71 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "CRE"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "have"

Phrase: "been"

Phrase: "enlarged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442800:Enlarged [Qualitative Concept]
  1000   C1293134:Enlarged [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "shown at right."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205090:Right [Spatial Concept]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.204: To identify some of the major factors bound to footprinted regions, we performed EMSAs with short oligonucleotide probes for these elements. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "some of the major factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205164:Major [Qualitative Concept]
   760   C0205392:Some [Quantitative Concept]
   760   C3540770:Some [Intellectual Product]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "bound to footprinted regions,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "EMSAs with short oligonucleotide probes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0596608:EMSA [Diagnostic Procedure]
   726   C0949632:EMSA [Laboratory Procedure]

Phrase: "for these elements."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013879:Elements [Element, Ion, or Isotope]
   966 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.205: Nuclear extracts prepared from normal and diabetic rats were used in this assay. 

Phrase: "Nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "prepared from normal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]
   756   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "used in this assay."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.206: By using the probe from 59 to 82, we observed strong binding that could be supershifted with two different NF-Y antisera but not with antisera to NF-1, an unrelated protein (Fig. 7A). 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the probe from 59"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0182400:Probe [Medical Device]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]

Phrase: "to 82,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "strong binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "supershifted with two different NF-Y antisera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0205448:Two [Quantitative Concept]
   748   C1705242:Different [Qualitative Concept]

Phrase: "but"

Phrase: "not with antisera"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C1518422:Not [Functional Concept]

Phrase: "to NF-1,"

Phrase: "an unrelated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.207: This confirms the presence of another NF-Y-binding site in the HMGR promoter, in addition to the one previously described upstream of the SRE (9). 

Phrase: "This"

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the presence of another NF-Y-binding site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the HMGR promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in addition to the one previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "described upstream of the SRE"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0038323:Sterol [Steroid]
   748   C0522505:Upstream [Spatial Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1552738:described [Idea or Concept]
   748   C1704632:Response [Finding]
   748   C1705248:Element [Conceptual Entity]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.208: NF-Y binding did not change in liver nuclear extracts, despite a marked difference in occupancy of this site in vivo (Fig. 6). 

Phrase: "NF-Y binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change in liver nuclear extracts,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   797   C0023899:Liver Extracts [Organic Chemical,Pharmacologic Substance]
   773   C1518434:Nuclear Extract [Biomedical or Dental Material]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C1705241:Change [Quantitative Concept]
   760   C2346688:LIVER [Food]
   726   C2828366:Extract [Substance]
   704 E C0205054:Hepatic [Body Location or Region]

Phrase: "despite a marked difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "in occupancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827063:Occupancy [Qualitative Concept]

Phrase: "of this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.209: A probe corresponding to the CRE was able to bind CREB-1 from normal and diabetic nuclear extracts (Fig. 7B). 

Phrase: "A probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "corresponding to the CRE"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   853   C1511573:Cyclic AMP Response Element [Gene or Genome]
   831   C1657589:response to cyclic AMP [Cell Function]
   778   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   778   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0439596:Cyclic [Temporal Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1511572:Cyclic [Temporal Concept]
   748   C1704632:Response [Finding]
   748   C1705248:Element [Conceptual Entity]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "CREB-1 from normal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1447703:CREB-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   867   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   793   C2828366:Extract [Substance]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.210: Overall binding to the CRE was not different between normal and diabetic extracts, as expected from the footprinting. 

Phrase: "Overall binding to the CRE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   855   C3158668:cyclic-AMP response element binding [Genetic Function]
   793   C1148918:cyclic AMP binding [Molecular Function]
   767   C1148922:AMP binding [Molecular Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "not different between normal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic extracts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "as"

Phrase: "expected from the footprinting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.211: Probes for the 119/142 and 129/152 regions showed strong binding of an unknown factor, whose in vitro binding ability was unaffected by diabetes (Fig. 7C). 

Phrase: "Probes for the 119/142"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0182400:Probes [Medical Device]
   726 E C1704681:Probe [Gene or Genome]
   726 E C2347609:Probe [Chemical Viewed Functionally]
   726 E C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "129/152 regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "strong binding of an unknown factor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "whose in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "ability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085732:Ability [Organism Attribute]
   928 E C1299581:Able [Finding]

Phrase: "was"

Phrase: "unaffected by diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]

Phrase: "(Fig. 7C"

Phrase: ")."
Processing 00000000.tx.212: View larger version (66K): [in this window] [in a new window]  FIGURE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(66K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 4."
Processing 00000000.tx.213: In vivo footprint of the hepatic HMGR promoter, bottom strand. 

Phrase: "In vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "footprint of the hepatic HMGR promoter,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205054:Hepatic [Body Location or Region]
   739   C0700307:Hydroxy [Inorganic Chemical]

Phrase: "bottom strand."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704972:Strand [Spatial Concept]
   861   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.214: Livers from normal (N) or diabetic (D) rats were treated with dimethyl sulfate to methylate-exposed guanine residues. 

Phrase: "Livers from normal"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   841   C0577059:Liver normal [Finding]
   790   C0023884:Livers [Body Part, Organ, or Organ Component]
   756 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   756 E C1278929:Liver [Body Part, Organ, or Organ Component]
   756 E C2346688:LIVER [Food]
   718 E C0205054:Hepatic [Body Location or Region]

Phrase: "(N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "(D) rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "treated with dimethyl sulfate to"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0058229:Dimethylsulfate [Hazardous or Poisonous Substance,Organic Chemical]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0038720:Sulfate [Inorganic Chemical]
   760   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   760   C1522326:Treated [Functional Concept]
   760   C3536965:SULFATE [Element, Ion, or Isotope]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "methylate-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0746574:methylate [Pharmacologic Substance]

Phrase: "exposed guanine residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.215: DNA was footprinted by ligation-mediated PCR. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "footprinted by ligation-mediated PCR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023690:Ligation [Therapeutic or Preventive Procedure]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0677874:pCR [Finding]
Processing 00000000.tx.216: The Naked lane shows all reactive guanine residues. 

Phrase: "The Naked lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "all reactive guanine residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.217: Protected bases are indicated by a solid triangle, and areas of enhanced DMS reactivity are denoted with an open triangle. 

Phrase: "Protected bases"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   861   C0178499:bases [Chemical Viewed Functionally]
   861   C1626935:Bases [Quantitative Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C1527178:Basis [Functional Concept]
   827 E C1874451:Basis [Pharmacologic Substance]
   827 E C1880279:Base [Biomedical or Dental Material]
   777 E C0205112:Basal [Spatial Concept]
   768 E C0016617:Foundation [Organization]

Phrase: "are"

Phrase: "indicated by a solid triangle,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205119:Triangle [Conceptual Entity]
   760   C0205208:Solid [Qualitative Concept]
   760   C0302909:Solid [Substance]
   760   C1378566:Solid [Biomedical or Dental Material]
   760   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "areas of enhanced DMS reactivity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "are"

Phrase: "denoted with an open triangle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0175566:Open [Spatial Concept]
   760   C0205119:Triangle [Conceptual Entity]
Processing 00000000.tx.218: Right, the SRE, 142 region, and the CRE have been enlarged.  

Phrase: "Right,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "the SRE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "142 region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the CRE"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "have"

Phrase: "been"

Phrase: "enlarged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442800:Enlarged [Qualitative Concept]
  1000   C1293134:Enlarged [Therapeutic or Preventive Procedure]
Processing 00000000.tx.219: In an effort to identify the factor binding to the 119/142 region, we performed additional EMSAs. 

Phrase: "In an effort to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015264:Effort [Organism Function]

Phrase: "identify"

Phrase: "the factor binding to the 119/142 region,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "additional EMSAs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0596608:EMSA [Diagnostic Procedure]
   827   C0949632:EMSA [Laboratory Procedure]
Processing 00000000.tx.220: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.221: 8 shows an experiment in which a probe to the 119/142 region was incubated in a binding reaction with normal rat liver nuclear extract (Fig. 8, 2nd lane). 

Phrase: "8"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an experiment in which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0681814:Experiment [Research Activity]
   770   C1706386:Experiment [Conceptual Entity]

Phrase: "a probe to the 119/142 region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0182400:Probe [Medical Device]
   748   C1704681:Probe [Gene or Genome]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "incubated in a binding reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243122:binding [Functional Concept]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "with normal rat liver nuclear extract"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0023899:Liver Extract [Organic Chemical,Pharmacologic Substance]
   840   C1518434:Nuclear Extract [Biomedical or Dental Material]
   804   C0521447:Nuclear [Spatial Concept]
   804   C2828366:Extract [Substance]

Phrase: "(Fig. 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "2nd lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.222: An unlabeled double-stranded oligonucleotide was added in 10-fold molar excess relative to the hot probe in the remaining lanes. 

Phrase: "An unlabeled double-stranded oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "added in 10-fold molar excess"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0026367:Molar [Body Part, Organ, or Organ Component]
   753   C0332462:Fold [Spatial Concept]
   753   C1524062:Added [Functional Concept]
   753   C1880834:FOLD [Phenomenon or Process]
   753   C1979886:Excess [Qualitative Concept]
   719 E C1883712:Add [Functional Concept]

Phrase: "relative to the hot probe"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "in the remaining lanes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.223: The sequence at the top of Fig. 

Phrase: "The sequence at the top of Fig."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.224: 8 is the wild type promoter sequence, with an arrow highlighting the point mutation in each lane. 

Phrase: "8"

Phrase: "is"

Phrase: "the wild type promoter sequence,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "with an arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "highlighting"

Phrase: "the point mutation in each lane."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   753   C0026882:Mutation [Genetic Function]
   753   C1552961:Point [Quantitative Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   753   C2347617:point [Quantitative Concept]
Processing 00000000.tx.225: The upper band in Fig. 

Phrase: "The upper band in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]
Processing 00000000.tx.226: 8 can be efficiently competed away with the wild type competitor (3rd lane), and most of the mutant oligonucleotides. 

Phrase: "8"

Phrase: "can"

Phrase: "be"

Phrase: "efficiently"

Phrase: "competed"

Phrase: "away with the wild type competitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "(3rd lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "most of the mutant oligonucleotides."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205393:Most [Quantitative Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.227: Noteworthy exceptions are "C_AG" from 137 to 134 and the entire sequence "GGGCGGTT" between 129 and 122. 

Phrase: "Noteworthy exceptions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1554961:exception [Idea or Concept]
   827   C1705847:Exception [Conceptual Entity]

Phrase: "are """

Phrase: "C_AG"" from 137"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0312905:C Ag [Amino Acid, Peptide, or Protein,Immunologic Factor]
   819 E C0312907:ag c [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "to 134"

Phrase: "and"

Phrase: "the entire sequence ""GGGCGGTT"""

Phrase: "between 129"

Phrase: "and"

Phrase: "122."
Processing 00000000.tx.228: The presence of two binding sites explains why this band is seen as well in the overlapping 129/152 probe, albeit with weaker signal. 

Phrase: "The presence of two binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "explains"

Phrase: "why"

Phrase: "this band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "seen as well"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205170:Well [Qualitative Concept]
   790   C0205397:Seen [Qualitative Concept]
   790   C3146287:Well [Manufactured Object]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "in the overlapping 129/152 probe,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0182400:Probe [Medical Device]
   812   C1704681:Probe [Gene or Genome]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]

Phrase: "albeit with weaker signal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1710082:Signal [Phenomenon or Process]
   737   C0004093:Weak [Sign or Symptom]
   737   C1762617:Weak [Qualitative Concept]
Processing 00000000.tx.229: The sequence GGGCGGTT seems like a good match for Sp1, whose consensus sequence is "GGGGCGGGGC" with a strong requirement for the core GGGCGG (27). 

Phrase: "The sequence GGGCGGTT"

Phrase: "seems like a good match"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0150103:match [Research Activity]
   760   C0205170:Good [Qualitative Concept]
   760   C1708943:Match [Qualitative Concept]

Phrase: "for Sp1,"

Phrase: "whose consensus sequence is ""GGGGCGGGGC"""

Phrase: "with a strong requirement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514873:Requirement [Functional Concept]

Phrase: "for the core GGGCGG"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.230: Curiously, neither of our Sp1 antisera were able to supershift this band, nor was antibody to Egr-1, another GC-box binding protein (data not shown). 

Phrase: "Curiously,"

Phrase: "neither of our Sp1 antisera"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C3274651:Neither [Qualitative Concept]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "supershift"

Phrase: "this band,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "nor"

Phrase: "was"

Phrase: "antibody to Egr-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "another GC-box binding protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.231: The lower band in the 1st lane of Fig. 

Phrase: "The lower band in the 1st lane of Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0175723:Band [Medical Device]
   742   C0439645:Band [Spatial Concept]
   742   C1521913:band [Cell Component]
Processing 00000000.tx.232: 8 was found to be nonspecific, as it was present regardless of probe used. 

Phrase: "8"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "nonspecific,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205370:Non-specific [Qualitative Concept]
  1000   C0750540:Nonspecific [Idea or Concept]

Phrase: "as"

Phrase: "it"

Phrase: "was"

Phrase: "present regardless of probe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.233: Given the strong protection of the CRE seen in all the in vivo footprints, and the ability of CREB to bind in vitro, we wanted to find out if CREB was in fact bound in vivo to the hepatic HMGR promoter. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the strong protection of the CRE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1709736:Protection Element [Conceptual Entity]
   742   C1545588:Protection [Finding]

Phrase: "seen in all"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "the in vivo footprints,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "and"

Phrase: "the ability of CREB to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "we"

Phrase: "wanted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444647:Wanted [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "if"

Phrase: "CREB"

Phrase: "was in fact"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "to the hepatic HMGR promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.234: To accomplish this, liver sections from normal and diabetic rats were cross-linked with formaldehyde and subjected to chromatin immunoprecipitation analysis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accomplish"

Phrase: "this,"

Phrase: "liver sections from normal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "cross-linked with formaldehyde"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0178576:Cross Linked [Natural Phenomenon or Process]
   833   C0332220:cross linked [Functional Concept]
   770   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "subjected to chromatin immunoprecipitation analysis."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C1328856:chromatin immunoprecipitation [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1325550:chromatin [Cell Component]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.235: CREB-1 antibody was able to pull down the HMGR promoter from both normal and diabetic chromatin, whereas an isotype-matched antibody to an irrelevant nuclear protein was not (Fig. 9A). 

Phrase: "CREB-1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1447703:CREB-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "able to pull down"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C0580844:Able to pull [Finding]
   899 E C0580838:Ability to pull [Finding]
   812   C0580846:pull [Finding]
   756   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   756   C2626739:Lanugo [Eukaryote]

Phrase: "the HMGR promoter from both normal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "diabetic chromatin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   861   C1325550:chromatin [Cell Component]

Phrase: "whereas"

Phrase: "an isotype-matched antibody to an irrelevant nuclear protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   784   C1445860:Antibody to protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Protein antibody
   762   C0021017:Antibody Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0487261:Nuclear antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "not (Fig. 9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.236: The minor difference in intensity of this band between normal and diabetic samples was not reproducible, although CREB was clearly bound in both cases. 

Phrase: "The minor difference in intensity of this band"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "between normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "not reproducible,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C1514863:Reproducibility [Qualitative Concept]

Phrase: "although"

Phrase: "CREB"

Phrase: "was"

Phrase: "clearly"

Phrase: "bound in both cases."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0332297:bound [Spatial Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1533148:Cases [Quantitative Concept]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.237: This immunoprecipitation was not able to pull down exon 12 of the HMGR gene, confirming that DNA was sheared to an appropriate size. 

Phrase: "This immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "not able to pull down exon 12"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   845   C0580844:Able to pull [Finding]
   821 E C0580838:Ability to pull [Finding]
   795   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0085732:Able [Organism Attribute]
   795   C0580846:pull [Finding]
   795   C1299581:Able [Finding]
   795   C1518422:Not [Functional Concept]
   740   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   740   C2626739:Lanugo [Eukaryote]

Phrase: "of the HMGR gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017337:Gene [Gene or Genome]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "sheared to an appropriate size."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0175735:sheared [Medical Device]
   760   C0205013:sheared [Therapeutic or Preventive Procedure]
   760   C0456389:size [Spatial Concept]
   760   C1548787:Appropriate [Qualitative Concept]
Processing 00000000.tx.238: The inability of phospho-CREB to pull down the HMGR promoter could be a result of poor antibody-antigen interaction. 

Phrase: "The inability of phospho-CREB"

Phrase: "to pull down"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0580846:pull [Finding]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "the HMGR promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "could"

Phrase: "be"

Phrase: "a result of poor antibody-antigen interaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
Processing 00000000.tx.239: We would expect that at least some of the endogenous CREB is phosphorylated. 

Phrase: "We"

Phrase: "would"

Phrase: "expect"

Phrase: "that at least"

Phrase: "some of the endogenous CREB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205227:Endogenous [Functional Concept]
   760   C0205392:Some [Quantitative Concept]
   760   C3540770:Some [Intellectual Product]

Phrase: "is"

Phrase: "phosphorylated."
Processing 00000000.tx.240: The data confirm reports that CREB is bound to the HMGR promoter in vivo (25) and validates this observation in the context of the live animal. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that CREB"

Phrase: "is"

Phrase: "bound to the HMGR promoter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0332297:bound [Spatial Concept]
   742   C0700307:Hydroxy [Inorganic Chemical]
   742   C1145667:Bound [Activity]
   742   C1167622:Bound [Molecular Function]
   742   C1689898:% bound [Quantitative Concept]
   742   C2349209:Bound [Conceptual Entity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "validates"

Phrase: "this observation in the context of the live animal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0302523:Observation [Research Activity]
   742   C0700325:observation [Health Care Activity]
   742   C1964257:Observation [Diagnostic Procedure]
Processing 00000000.tx.241: View larger version (49K): [in this window] [in a new window]  FIGURE 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 5."
Processing 00000000.tx.242: In vivo footprinting of the HMGR promoter in rats fed lovastatin or cholesterol. 

Phrase: "In vivo footprinting of the HMGR promoter"

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "lovastatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "cholesterol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]
Processing 00000000.tx.243: Rats were fed either 0.02% lovastatin (L) or 1% cholesterol (Ch) chow for 5 days. 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "either 0.02% lovastatin (L)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "1% cholesterol (Ch) chow for 5 days."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0324335:chow [Mammal]
Processing 00000000.tx.244: Livers were treated with dimethyl sulfate and footprinted by ligation-mediated PCR. 

Phrase: "Livers"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0023884:Livers [Body Part, Organ, or Organ Component]
   966 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   966 E C1278929:Liver [Body Part, Organ, or Organ Component]
   966 E C2346688:LIVER [Food]
   928 E C0205054:Hepatic [Body Location or Region]

Phrase: "were"

Phrase: "treated with dimethyl sulfate"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0058229:Dimethylsulfate [Hazardous or Poisonous Substance,Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0038720:Sulfate [Inorganic Chemical]
   770   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   770   C1522326:Treated [Functional Concept]
   770   C3536965:SULFATE [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "footprinted by ligation-mediated PCR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0023690:Ligation [Therapeutic or Preventive Procedure]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0677874:pCR [Finding]
Processing 00000000.tx.245: Protected bases are indicated by a solid triangle, and whereas areas of enhanced DMS reactivity are denoted with an open triangle. 

Phrase: "Protected bases"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   861   C0178499:bases [Chemical Viewed Functionally]
   861   C1626935:Bases [Quantitative Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C1527178:Basis [Functional Concept]
   827 E C1874451:Basis [Pharmacologic Substance]
   827 E C1880279:Base [Biomedical or Dental Material]
   777 E C0205112:Basal [Spatial Concept]
   768 E C0016617:Foundation [Organization]

Phrase: "are"

Phrase: "indicated by a solid triangle,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205119:Triangle [Conceptual Entity]
   760   C0205208:Solid [Qualitative Concept]
   760   C0302909:Solid [Substance]
   760   C1378566:Solid [Biomedical or Dental Material]
   760   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "whereas"

Phrase: "areas of enhanced DMS reactivity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "are"

Phrase: "denoted with an open triangle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0175566:Open [Spatial Concept]
   760   C0205119:Triangle [Conceptual Entity]
Processing 00000000.tx.246: Right, the SRE (164/155) has been enlarged.  

Phrase: "Right,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "the SRE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "(164/155"

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "enlarged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442800:Enlarged [Qualitative Concept]
  1000   C1293134:Enlarged [Therapeutic or Preventive Procedure]
Processing 00000000.tx.247: View larger version (36K): [in this window] [in a new window]  FIGURE 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 6."
Processing 00000000.tx.248: Summary of DMS reactivity. 

Phrase: "Summary of DMS reactivity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552616:summary [Intellectual Product]
   770   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.249: Many areas of DMS protection and enhancement were observed by in vivo footprinting. 

Phrase: "Many areas of DMS protection"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "and"

Phrase: "enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1627358:Enhancement [Therapeutic or Preventive Procedure]
  1000   C2349975:Enhancement [Activity]

Phrase: "were"

Phrase: "observed by in vivo footprinting."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1515655:In Vivo [Spatial Concept]
           vivo
   760   C1441672:Observed [Functional Concept]
Processing 00000000.tx.250: The most common and reproducible sites are noted. 

Phrase: "The most common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205214:Common [Quantitative Concept]
   861   C1522138:Common [Functional Concept]
   861   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "reproducible sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.251: Protected bases are indicated by a solid triangle, and areas of enhanced DMS reactivity are denoted with an open triangle. 

Phrase: "Protected bases"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   861   C0178499:bases [Chemical Viewed Functionally]
   861   C1626935:Bases [Quantitative Concept]
   827 E C0002055:base [Inorganic Chemical]
   827 E C1527178:Basis [Functional Concept]
   827 E C1874451:Basis [Pharmacologic Substance]
   827 E C1880279:Base [Biomedical or Dental Material]
   777 E C0205112:Basal [Spatial Concept]
   768 E C0016617:Foundation [Organization]

Phrase: "are"

Phrase: "indicated by a solid triangle,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205119:Triangle [Conceptual Entity]
   760   C0205208:Solid [Qualitative Concept]
   760   C0302909:Solid [Substance]
   760   C1378566:Solid [Biomedical or Dental Material]
   760   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "areas of enhanced DMS reactivity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "are"

Phrase: "denoted with an open triangle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0175566:Open [Spatial Concept]
   760   C0205119:Triangle [Conceptual Entity]
Processing 00000000.tx.252: The nucleotide position is given relative to the transcription start site. 

Phrase: "The nucleotide position"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "is"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "relative to the transcription start site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.253: Five normal (N) and five diabetic (D) animals were footprinted. 

Phrase: "Five normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]

Phrase: "(N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "five diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0241863:DIABETIC [Finding]

Phrase: "(D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: ")"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "footprinted."
Processing 00000000.tx.254: The number of times each protection or enhancement was observed is expressed as a fraction of the total animals in the group. 

Phrase: "The number of times"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C0449809:Number of times [Quantitative Concept]
           number times
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "each protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "or"

Phrase: "enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1627358:Enhancement [Therapeutic or Preventive Procedure]
  1000   C2349975:Enhancement [Activity]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "is"

Phrase: "expressed as a fraction of the total animals"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C0439160:Fraction of total [Quantitative Concept]
   770   C1264633:Fraction of [Quantitative Concept]
           Fraction
   744   C0003062:Animals [Animal]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C1554103:Fraction [Idea or Concept]

Phrase: "in the group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.255: In the sequence column, the sequence is given, showing the reactive residue that was detected. 

Phrase: "In the sequence column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the reactive residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.256: Possible factors that may bind are listed in the last column. 

Phrase: "Possible factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "are"

Phrase: "listed in the last column."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1185738:Column [Body Part, Organ, or Organ Component]
   760   C1706132:Column [Idea or Concept]
   726   C0745732:List [Conceptual Entity]
   726   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.257: Major differences are in A, and common elements are in B.  

Phrase: "Major differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "are in A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]

Phrase: "and"

Phrase: "common elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "are in B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]
Processing 00000000.tx.258: View larger version (59K): [in this window] [in a new window]  FIGURE 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(59K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 7."
Processing 00000000.tx.259: EMSA analysis of footprinted regions. 

Phrase: "EMSA analysis of footprinted regions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.260: Short DNA probes corresponding to the major footprinted areas were used to detect in vitro protein binding in normal (N) and diabetic (D) rat liver nuclear extracts. 

Phrase: "Short DNA probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0012893:DNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0182400:Probes [Medical Device]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]

Phrase: "corresponding to the major footprinted areas"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0205146:areas [Spatial Concept]
   753   C0205164:Major [Qualitative Concept]
   719 E C0017446:Area [Geographic Area]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "in vitro protein binding in normal"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0033618:Protein Binding [Molecular Function]
   783 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0860902:normal protein [Finding]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "(N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "(D) rat liver nuclear extracts."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0023899:Liver Extracts [Organic Chemical,Pharmacologic Substance]
   806   C1518434:Nuclear Extract [Biomedical or Dental Material]
   804   C0521447:Nuclear [Spatial Concept]
   771   C2828366:Extract [Substance]
Processing 00000000.tx.261: A, probe to the 59/82 region, with two different NF-Y antisera or NF-1 antisera added as indicated. 

Phrase: "A,"

Phrase: "probe to the 59/82 region,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0182400:Probe [Medical Device]
   753   C1704681:Probe [Gene or Genome]
   753   C2347609:Probe [Chemical Viewed Functionally]
   753   C3536729:Probe [Manufactured Object]

Phrase: "with two different NF-Y antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "NF-1 antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.262: B, probe for the CRE (85/115) with CREB-1 antisera added where indicated. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "probe for the CRE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1441707:Probe.amp [Laboratory Procedure]
   748   C0182400:Probe [Medical Device]
   748   C1704681:Probe [Gene or Genome]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C3536729:Probe [Manufactured Object]

Phrase: "(85/115"

Phrase: ")"

Phrase: "with CREB-1 antisera"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1447703:CREB-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "where"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.263: C, probe for the 119/142 and the 129/152 regions.  

Phrase: "C,"

Phrase: "probe for the 119/142"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0182400:Probe [Medical Device]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "the 129/152 regions."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.264: View larger version (71K): [in this window] [in a new window]  FIGURE 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(71K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 8."
Processing 00000000.tx.265: EMSA analysis of Sp1-like factor binding to the 119/142 region. 

Phrase: "EMSA analysis of Sp1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "like factor binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "to the 119/142 region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.266: A short DNA probe corresponding to the footprinted region between 119 and 142 was used to detect in vitro binding ability in rat liver nuclear extracts. 

Phrase: "A short DNA probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0012893:DNA probe [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0182400:Probe [Medical Device]
   827   C1704681:Probe [Gene or Genome]
   827   C2347609:Probe [Chemical Viewed Functionally]
   827   C3536729:Probe [Manufactured Object]

Phrase: "corresponding to the footprinted region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "between 119"

Phrase: "and"

Phrase: "142"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "in vitro binding ability in rat liver nuclear extracts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0085732:Ability [Organism Attribute]
Processing 00000000.tx.267: Competitor oligonucleotides were used in a 10-fold molar excess to the probe where indicated. 

Phrase: "Competitor oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "used in a 10-fold molar excess"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0026367:Molar [Body Part, Organ, or Organ Component]
   748   C0332462:Fold [Spatial Concept]
   748   C1273517:used [Finding]
   748   C1880834:FOLD [Phenomenon or Process]
   748   C1979886:Excess [Qualitative Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "to the probe where"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.268: The 1st lane () is a binding reaction without nuclear extract. 

Phrase: "The 1st lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "("

Phrase: ")"

Phrase: "is"

Phrase: "a binding reaction without nuclear extract."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.269: The 2nd lane (none) is a binding reaction with rat liver nuclear extract but no competitor. 

Phrase: "The 2nd lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "("

Phrase: "none"

Phrase: ")"

Phrase: "is"

Phrase: "a binding reaction with rat liver nuclear extract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]

Phrase: "but"

Phrase: "no competitor."
Processing 00000000.tx.270: The 3rd lane (w.t.) is a binding reaction with the wild type sequence used as a competitor. 

Phrase: "The 3rd lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "(w.t.)"

Phrase: "is"

Phrase: "a binding reaction with the wild type sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]

Phrase: "used as a competitor."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.271: The remaining lanes are labeled with the wild type promoter sequence on top, and an arrow pointing to the point mutation in the competitor oligonucleotide.  

Phrase: "The remaining lanes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "are"

Phrase: "labeled with the wild type promoter sequence"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1519249:Sequence [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1708632:Labeled [Qualitative Concept]
   714 E C0181496:Label [Manufactured Object]
   714 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "on top,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "an arrow pointing to the point mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   714   C1552961:Point [Quantitative Concept]
   714   C2347617:point [Quantitative Concept]

Phrase: "in the competitor oligonucleotide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.272: Another point of interest in the in vivo footprints was the consistent protection of the NF-Y site identified at 70. 

Phrase: "Another point of interest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "in the in vivo footprints"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "was"

Phrase: "the consistent protection of the NF-Y site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1545588:Protection [Finding]

Phrase: "identified at 70."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
Processing 00000000.tx.273: Because this site was strongly protected in 4/5 of the normal footprints, and none of the diabetics, we hypothesized that this element might play a critical role in activation of transcription. 

Phrase: "Because"

Phrase: "this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "strongly"

Phrase: "protected in 4/5 of the normal footprints,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205307:Normal [Qualitative Concept]
   744   C0439166:% normal [Quantitative Concept]
   744   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "none of the diabetics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0241863:diabetics [Finding]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "this element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013879:Element [Element, Ion, or Isotope]
  1000   C1705248:Element [Conceptual Entity]

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in activation of transcription."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.274: In order to investigate a possible functional role for this site, we constructed luciferase reporter plasmids containing the full-length HMG-CoA reductase promoter starting at 325 and ending at +70 of the 5'-untranslated region. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "a possible functional role for this site,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1705810:Functional Role [Conceptual Entity]
           Role
   774   C2347795:Site Role [Idea or Concept]
   748   C0035820:Role [Social Behavior]

Phrase: "we"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "luciferase reporter plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the full-length HMG-CoA reductase promoter starting at 325"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0439659:Start [Temporal Concept]

Phrase: "and"

Phrase: "ending at +70 of the 5'-untranslated region."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C0444930:ending [Spatial Concept]
   744   C2746065:Ending [Temporal Concept]
Processing 00000000.tx.275: Two identical plasmids harboring mutations in the NF-Y site were also made. 

Phrase: "Two identical plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "mutations in the NF-Y site"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "also"

Phrase: "made."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]
Processing 00000000.tx.276: These plasmids were transfected into H4IIE cells, a rat hepatoma line. 

Phrase: "These plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "transfected into H4IIE cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "a rat hepatoma line."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.277: The cells were harvested and assayed for luciferase activity (Renilla luciferase was co-transfected for normalization purposes). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "assayed for luciferase activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1151115:luciferase activity [Molecular Function]
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "(Renilla luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "co-transfected for normalization purposes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1285529:purposes [Functional Concept]
   760   C1882115:Normalization [Research Activity]

Phrase: ")."
Processing 00000000.tx.278: As seen in Fig. 

Phrase: "As"

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.279: 10, the wild type promoter shows a high level of activity relative to the vector backbone. 

Phrase: "10,"

Phrase: "the wild type promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a high level of activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0683317:Activity level [Finding]
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299351:High [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700149:HIGH [Intellectual Product]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "relative to the vector backbone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.280: Both of the mutants significantly inhibited luciferase production, indicating that this NF-Y site is required for efficient HMGR transcription. 

Phrase: "Both of the mutants significantly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0238767:Both [Spatial Concept]
   760   C0596988:mutants [Cell or Molecular Dysfunction]
   760   C1706086:Both [Qualitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "luciferase production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "indicating"

Phrase: "that"

Phrase: "this NF-Y site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "required for efficient HMGR transcription."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0040649:Transcription [Genetic Function]
   742   C0442799:Efficient [Qualitative Concept]
   742   C0700307:Hydroxy [Inorganic Chemical]
   742   C1514873:Required [Functional Concept]
Processing 00000000.tx.281: View larger version (27K): [in this window] [in a new window]  FIGURE 9. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 9."
Processing 00000000.tx.282: CREB is bound to the HMGR promoter in live animals. 

Phrase: "CREB"

Phrase: "is"

Phrase: "bound to the HMGR promoter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0332297:bound [Spatial Concept]
   742   C0700307:Hydroxy [Inorganic Chemical]
   742   C1145667:Bound [Activity]
   742   C1167622:Bound [Molecular Function]
   742   C1689898:% bound [Quantitative Concept]
   742   C2349209:Bound [Conceptual Entity]

Phrase: "in live animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.283: Liver pieces from normal (N) and diabetic (D) rats were cross-linked in 1% formaldehyde. 

Phrase: "Liver pieces from normal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2982836:Piece [Quantitative Concept]

Phrase: "(N"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "(D) rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "cross-linked in 1% formaldehyde."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0178576:Cross Linked [Natural Phenomenon or Process]
   806   C0332220:cross linked [Functional Concept]
   760   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.284: Nuclei were isolated and lysed. 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "lysed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]
Processing 00000000.tx.285: Chromatin was sonicated to an average size of 200600 bp. 

Phrase: "Chromatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
  1000   C1325550:chromatin [Cell Component]

Phrase: "was"

Phrase: "sonicated to an average size of 200600 bp."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0456389:size [Spatial Concept]
   744   C1510992:Average [Quantitative Concept]
   744   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.286: 15 g of chromatin was immunoprecipitated (IP) with no antibody (beads), an irrelevant antibody (Irr. Ab) (USF-2), CREB-1 antibody, or phospho-CREB antibody. 

Phrase: "15 g of chromatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "immunoprecipitated (IP) with no antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "an irrelevant antibody (Irr. Ab)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(USF-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0076925:USF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1706445:USF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "CREB-1 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1447703:CREB-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "phospho-CREB antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.287: Forty cycles of PCR were performed, and products were run on a 2.2% agarose gel with ethidium bromide. 

Phrase: "Forty cycles of PCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1511572:Cycle [Temporal Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "and"

Phrase: "products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "a 2.2% agarose gel with ethidium bromide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1706746:Agarose Gel [Research Device]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C1382104:Gel [Substance]
Processing 00000000.tx.288: A, PCR to detect the HMG-CoA reductase promoter. 

Phrase: "A,"

Phrase: "PCR to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the HMG-CoA reductase promoter."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415615:HMG-CoA REDUCTASE [Gene or Genome]
Processing 00000000.tx.289: B, PCR to detect HMG-CoA reductase Exon 12.   

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "PCR to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "HMG-CoA reductase Exon 12."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415615:HMG-CoA REDUCTASE [Gene or Genome]
   840   C0047420:HMG-CoA [Biologically Active Substance,Organic Chemical]
   804   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.290: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  These studies address the regulation of the HMG-CoA reductase promoter by insulin in live animals. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the regulation of the HMG-CoA reductase promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in live animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.291: Here we present the first evidence that insulin acts to directly increase transcription of the HMG-CoA reductase gene in rat liver. 

Phrase: "Here"

Phrase: "we"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "the first evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "transcription of the HMG-CoA reductase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "in rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.292: Diabetic rats have lower rates of HMG-CoA reductase transcription than normal rats. 

Phrase: "Diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "have"

Phrase: "lower rates of HMG-CoA reductase transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "than normal rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.293: With only 2 h of insulin treatment, transcription was restored to normal. 

Phrase: "With only 2 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "of insulin treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "was"

Phrase: "restored to normal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.294: Previous work from our lab showed that the corresponding increase in mRNA could be accomplished even in the presence of cycloheximide (6). 

Phrase: "Previous work from our lab"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043227:Work [Occupational Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the corresponding increase in mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "accomplished"

Phrase: "even in the presence of cycloheximide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.295: Taken together, these results suggest that insulin acts rather directly to stimulate the HMG-CoA reductase promoter and does not require protein synthesis. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "rather directly to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1947931:Directly [Qualitative Concept]

Phrase: "stimulate"

Phrase: "the HMG-CoA reductase promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415615:HMG-CoA REDUCTASE [Gene or Genome]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "protein synthesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]
Processing 00000000.tx.296: In vivo footprinting revealed numerous protections and enhancements throughout the HMGR promoter. 

Phrase: "In vivo footprinting revealed numerous protections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1545588:Protection [Finding]

Phrase: "and"

Phrase: "enhancements throughout the HMGR promoter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   708   C2349975:Enhancement [Activity]
Processing 00000000.tx.297: The most pronounced of these was at the CRE, which was occupied under all conditions tested. 

Phrase: "The most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "pronounced of these"

Phrase: "was at the CRE,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   853   C1511573:Cyclic AMP Response Element [Gene or Genome]
   778   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   778   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0013879:Element [Element, Ion, or Isotope]
   748   C0043194:WAS [Disease or Syndrome]
   748   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439596:Cyclic [Temporal Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1421478:WAS [Gene or Genome]
   748   C1511572:Cyclic [Temporal Concept]
   748   C1704632:Response [Finding]
   748   C1705248:Element [Conceptual Entity]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "which"

Phrase: "was"

Phrase: "occupied under all conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1548223:Occupied [Idea or Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.298: EMSA analysis confirmed that CREB-1 present in nuclear extracts from normal or diabetic rat livers could bind to this element in vitro, in agreement with observations in FRTL-5 cells (10). 

Phrase: "EMSA analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that CREB-1 present in nuclear extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "from normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "or"

Phrase: "diabetic rat livers"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   867   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   827   C0023884:Livers [Body Part, Organ, or Organ Component]
   793 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   793 E C1278929:Liver [Body Part, Organ, or Organ Component]
   793 E C2346688:LIVER [Food]
   755 E C0205054:Hepatic [Body Location or Region]

Phrase: "could"

Phrase: "bind to this element"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0013879:Element [Element, Ion, or Isotope]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1705248:Element [Conceptual Entity]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "in FRTL-5 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.299: Chromatin immunoprecipitation analysis of rat liver confirms the previous finding that CREB is bound to the HMGR promoter in vivo (25). 

Phrase: "Chromatin immunoprecipitation analysis of rat liver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the previous finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "that CREB"

Phrase: "is"

Phrase: "bound to the HMGR promoter"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0332297:bound [Spatial Concept]
   742   C0700307:Hydroxy [Inorganic Chemical]
   742   C1145667:Bound [Activity]
   742   C1167622:Bound [Molecular Function]
   742   C1689898:% bound [Quantitative Concept]
   742   C2349209:Bound [Conceptual Entity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.300: Given the overwhelming and invariant occupancy of the CRE in vivo, it seems unlikely that CREB binding is the regulated event in insulin activation. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the overwhelming"

Phrase: "and"

Phrase: "invariant occupancy of the CRE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2827063:Occupancy [Qualitative Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "it"

Phrase: "seems"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that CREB binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1149372:CREB binding [Genetic Function]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "the regulated event in insulin activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441471:Event [Event]
Processing 00000000.tx.301: This may differ from sterol regulation in which SREBP binding has been shown to selectively recruit CREB to the promoter in CHO cells (28). 

Phrase: "This"

Phrase: "may"

Phrase: "differ from sterol regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0038323:Sterol [Steroid]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "in which SREBP binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to selectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "recruit"

Phrase: "CREB to the promoter"

Phrase: "in CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.302: Although we previously showed that the CRE was required for insulin activation of this promoter in H4IIE cells (7), in vivo occupancy of this site did not vary in rat liver. 

Phrase: "Although"

Phrase: "we previously"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the CRE"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "was"

Phrase: "required for insulin activation of this promoter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1514873:Required [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1879547:Activation [Activity]

Phrase: "in H4IIE cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "in vivo occupancy of this site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2827063:Occupancy [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "vary in rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.303: It is possible that insulin regulation in cultured rat hepatoma cells differs from the physiological regulation of this gene seen in whole animals. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that insulin regulation in cultured rat hepatoma cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "differs from the physiological regulation of this gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0017263:Gene Regulation [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0205463:Physiological [Functional Concept]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "seen in whole animals."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   816   C0229961:Whole Animal [Fully Formed Anatomical Structure]
   770   C0003062:Animals [Animal]
   770   C0205397:Seen [Qualitative Concept]
   770   C0444667:Whole [Quantitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
Processing 00000000.tx.304: It is also possible that the CRE is necessary but not sufficient for insulin activation, inasmuch as it is required for maintaining an appropriate level of basal transcriptional activity. 

Phrase: "It"

Phrase: "is"

Phrase: "also possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the CRE"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "is"

Phrase: "necessary"

Phrase: "but"

Phrase: "not sufficient for insulin activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205410:Sufficient [Qualitative Concept]

Phrase: "inasmuch as"

Phrase: "it"

Phrase: "is"

Phrase: "required for maintaining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514873:Required [Functional Concept]
   756   C0024501:Maintain [Activity]

Phrase: "an appropriate level of basal transcriptional activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0683317:Activity level [Finding]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.305: The enhancement at 138 in normal footprints was not seen in diabetic samples. 

Phrase: "The enhancement at 138"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "in normal footprints"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen in diabetic samples."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205397:Seen [Qualitative Concept]
   770   C0241863:DIABETIC [Finding]
   737 E C0042789:see [Organism Function]
   737   C0370003:Sample [Substance]
   737 E C1947903:See [Activity]
   737   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.306: Given the GC-rich content of the nearby sequence, it is likely that this may be due to binding of an Sp1-related factor. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the GC-rich content of the nearby sequence,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "this"

Phrase: "may"

Phrase: "be due to binding of an Sp1-related factor."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0243122:binding [Functional Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2987476:Be [Conceptual Entity]
   742   C3146286:Due [Idea or Concept]
Processing 00000000.tx.307: In fact, strong in vitro binding activity was observed with the probe from 119 to 142. 

Phrase: "In fact,"

Phrase: "strong in vitro binding activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C2266866:Binding Activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "observed with the probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0182400:Probe [Medical Device]
   770   C1441672:Observed [Functional Concept]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]

Phrase: "from 119"

Phrase: "to 142."
Processing 00000000.tx.308: The sequence "gggcggctt" is a close match to the consensus binding sequence for Sp1. 

Phrase: "The sequence ""gggcggctt"""

Phrase: "is"

Phrase: "a close match to the consensus binding sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150103:match [Research Activity]
   744   C1708943:Match [Qualitative Concept]

Phrase: "for Sp1."
Processing 00000000.tx.309: Although generally regarded as a more basal transcription factor, Sp1 has been invoked in the insulin regulation of several genes, including SREBP-1a (29). 

Phrase: "Although"

Phrase: "generally"

Phrase: "regarded as a more basal transcription factor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C1135650:Basal Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0960756:factor A [Organic Chemical]
   748   C0040649:Transcription [Genetic Function]
   748   C0205112:Basal [Spatial Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "Sp1"

Phrase: "has"

Phrase: "been"

Phrase: "invoked in the insulin regulation of several genes,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0017263:genes regulation [Genetic Function]
   750   C1337112:Insulin Gene [Gene or Genome]
   744   C0017337:Genes [Gene or Genome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "SREBP-1a"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0753747:SREBP-1a [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.310: View larger version (14K): [in this window] [in a new window]  FIGURE 10. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 10."
Processing 00000000.tx.311: The NF-Y site at 70 is required for efficient transcription of HMG-CoA reductase. 

Phrase: "The NF-Y site at 70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "required for efficient transcription of HMG-CoA reductase."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0020374:HMG CoA Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0063164:HMG-CoA reductase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1415615:HMG-CoA REDUCTASE [Gene or Genome]
   770   C0047420:HMG-CoA [Biologically Active Substance,Organic Chemical]
   744   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0040649:Transcription [Genetic Function]
   744   C0442799:Efficient [Qualitative Concept]
   744   C1514873:Required [Functional Concept]
Processing 00000000.tx.312: A, H4IIE cells were transfected with pGL3 basic, the wild type HMG-CoA reductase promoter-luciferase construct (W.T.), or the same plasmid harboring mutations in the NF-Y site (Mut A and Mut B). 

Phrase: "A,"

Phrase: "H4IIE cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with pGL3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1854336:PGL3 [Disease or Syndrome]
   790   C3273620:PGL3 [Gene or Genome]

Phrase: "basic,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527178:Basic [Functional Concept]
   928 E C0920750:basicity [Quantitative Concept]

Phrase: "the wild type HMG-CoA reductase promoter-luciferase construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "(W.T."

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "the same plasmid harboring mutations in the NF-Y site"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0026882:Mutations [Genetic Function]
   706 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Mut A"

Phrase: "and"

Phrase: "Mut B"

Phrase: ")."
Processing 00000000.tx.313: For normalization purposes, each construct was co-transfected with pRL-TK, a plasmid containing the Renilla luciferase gene driven by the thymidine kinase promoter. 

Phrase: "For normalization purposes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285529:purposes [Functional Concept]

Phrase: "each construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "co-transfected with pRL-TK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0220928:TK [Geographic Area]

Phrase: "a plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the Renilla luciferase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1334435:Luciferase Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "driven by the thymidine kinase promoter."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0040078:Thymidine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   719   C0013126:Drive [Mental Process]
Processing 00000000.tx.314: Relative luciferase units (R.L.U.) are expressed as the ratio of firefly to Renilla luciferase  S.D. 

Phrase: "Relative luciferase units (R.L.U.)"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as the ratio of firefly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0162328:Firefly [Eukaryote]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "to Renilla luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "S."

Phrase: "D."
Processing 00000000.tx.315: B, schematic of the HMG-CoA reductase promoter-luciferase construct in pGL3. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "schematic of the HMG-CoA reductase promoter-luciferase construct"

Phrase: "in pGL3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1854336:PGL3 [Disease or Syndrome]
  1000   C3273620:PGL3 [Gene or Genome]
Processing 00000000.tx.316: C, sequence of the NF-Y site in the mutant plasmids from 69 to 65.  

Phrase: "C,"

Phrase: "sequence of the NF-Y site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "in the mutant plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from 69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "to 65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]
Processing 00000000.tx.317: Four of the five diabetic animals showed a particularly striking enhancement at 142. 

Phrase: "Four of the five diabetic animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0003062:Animals [Animal]
   753   C0205450:Four [Quantitative Concept]
   753   C0205451:Five [Quantitative Concept]
   753   C0241863:DIABETIC [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a particularly"

Phrase: "striking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038452:striking [Occupational Activity]

Phrase: "enhancement at 142."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   790   C2349975:Enhancement [Activity]
Processing 00000000.tx.318: This enhancement was never seen under the other conditions examined, including cholesterol and lovastatin treatment. 

Phrase: "This enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1627358:Enhancement [Therapeutic or Preventive Procedure]
  1000   C2349975:Enhancement [Activity]

Phrase: "was"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "seen under the"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "other conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "lovastatin treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.319: In addition, only diabetic samples showed a change in the DMS reactivity of the SRE. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "only diabetic samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a change in the DMS reactivity of the SRE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0392747:Change [Functional Concept]
   738   C0443172:change [Quantitative Concept]
   738   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.320: This enhancement at 161 of the SRE coincided with the enhancement at 142 and may be a result of binding of a repressive factor in the 161/142 region. 

Phrase: "This enhancement at 161 of the SRE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   742   C2349975:Enhancement [Activity]

Phrase: "coincided with the enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "at 142"

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "a result of binding of a repressive factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "in the 161/142 region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.321: Binding of a factor in this region could distort the DNA in such a way that both 142 and 161 are more susceptible to dimethyl sulfate attack. 

Phrase: "Binding of a factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "in this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "could"

Phrase: "distort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700135:distort [Functional Concept]

Phrase: "the DNA in such"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a way"

Phrase: "that"

Phrase: "both 142"

Phrase: "and"

Phrase: "161"

Phrase: "are"

Phrase: "more susceptible to dimethyl sulfate attack."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231204:Susceptible [Functional Concept]
   753   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
Processing 00000000.tx.322: In addition, this factor may preclude binding to the Sp1 site downstream of 138. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "this factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "preclude"

Phrase: "binding to the Sp1 site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0005456:Binding Site [Receptor]
   797   C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "downstream of 138."
Processing 00000000.tx.323: This competition would explain why enhancements at 138 were only seen in the normal animals (due to binding at Sp1 sites) and the enhancement at 142 only in the diabetic animals. 

Phrase: "This competition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679932:competition [Social Behavior]

Phrase: "would"

Phrase: "explain"

Phrase: "why enhancements at 138"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   737   C2349975:Enhancement [Activity]

Phrase: "were"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "seen in the normal animals"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0003062:Animals [Animal]
   760   C0205307:Normal [Qualitative Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C2347086:% Normal [Quantitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "("

Phrase: "due to binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "at Sp1 sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the enhancement at 142 only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "in the diabetic animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.324: When animals were fed either lovastatin or cholesterol, the footprint looked essentially identical to that seen in normal animals. 

Phrase: "When"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "either lovastatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "cholesterol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "the footprint"

Phrase: "looked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0233426:look [Organism Attribute]

Phrase: "essentially identical to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205280:Identical [Qualitative Concept]

Phrase: "seen in normal animals."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0003062:Animals [Animal]
   770   C0205307:Normal [Qualitative Concept]
   770   C0205397:Seen [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
Processing 00000000.tx.325: This is peculiar because a similar dose of lovastatin was shown to elevate HMGR transcription 46-fold (22). 

Phrase: "This"

Phrase: "is"

Phrase: "peculiar"

Phrase: "because"

Phrase: "a similar dose of lovastatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0178602:Dose [Quantitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "HMGR transcription 46-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0332462:Fold [Spatial Concept]
   793   C1880834:FOLD [Phenomenon or Process]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.326: Three possible reasons for the lack of occupancy at the SRE come to mind. 

Phrase: "Three possible reasons for the lack of occupancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392360:reasons [Idea or Concept]

Phrase: "at the SRE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "come"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mind."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0229992:Mind, NOS [Mental Process]
Processing 00000000.tx.327: 1) SREBP binding has been proposed to be a rapid and transient event. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "SREBP binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "transient event."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]
Processing 00000000.tx.328: It is known that SREBPs are by themselves weak binders of DNA, suggesting that nearby factors are needed to stabilize them (25). 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that SREBPs"

Phrase: "are by themselves weak binders of DNA,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0004093:Weak [Sign or Symptom]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0179302:binders [Medical Device]
   748   C1551058:Are [Quantitative Concept]
   748   C1762617:Weak [Qualitative Concept]
   714 E C1706253:Binder [Biomedical or Dental Material]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that nearby factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "them"

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.329: Therefore, SREBPs may not occupy their binding site in a large enough percentage of cells to show up in the footprint. 

Phrase: "Therefore,"

Phrase: "SREBPs"

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occupy"

Phrase: "their binding site in a large enough percentage of cells to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   756   C0005456:Binding Site [Receptor]
   756   C0682969:Binding Site [Amino Acid Sequence]
   754   C2945843:Site of [Qualitative Concept]
   738   C0205145:Site [Spatial Concept]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1515974:Site [Body Location or Region]
   738   C2825164:Site [Spatial Concept]

Phrase: "show up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1547282:Show [Intellectual Product]

Phrase: "in the footprint."
Processing 00000000.tx.330: 2) Lovastatin activation of this gene could occur through another site elsewhere in the promoter. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "Lovastatin activation of this gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0017255:Gene Activation [Genetic Function]
   760   C1879547:Activation [Activity]

Phrase: "could"

Phrase: "occur through another site elsewhere"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C2825164:Site [Spatial Concept]

Phrase: "in the promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.331: This seems reasonable because HMGR is known to have a variant SRE, with lower affinity for SREBPs than those found in the low density lipoprotein receptor and HMG-CoA synthase. 

Phrase: "This"

Phrase: "seems"

Phrase: "reasonable"

Phrase: "because"

Phrase: "HMGR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a variant SRE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "with lower affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for SREBPs"

Phrase: "than those"

Phrase: "found in the low density lipoprotein receptor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   853   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   853   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   814   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   778   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0599283:receptor density [Genetic Function]
   748   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0150312:Found [Quantitative Concept]
   748   C0178587:density [Quantitative Concept]
   748   C0205251:low [Qualitative Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1299352:Low [Qualitative Concept]
   748   C1550472:low [Idea or Concept]
   714 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "HMG-CoA synthase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020375:HMG-CoA synthase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0047420:HMG-CoA [Biologically Active Substance,Organic Chemical]
   901   C1428910:CoA synthase [Gene or Genome]
   827   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.332: It has also been demonstrated that SREBP-1 can bind to the HMGR promoter at sites other than the SRE (11). 

Phrase: "It"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that SREBP-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0217529:SREBP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "bind to the HMGR promoter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0700307:Hydroxy [Inorganic Chemical]
   742   C1145667:Bind [Activity]
   742   C1167622:bind [Molecular Function]

Phrase: "at sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "other than the SRE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.333: 3) Perhaps not all of the cells in the liver respond to lovastatin. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "Perhaps"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all of the cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0444868:All [Quantitative Concept]
   770   C3282337:Cells [Cell]
   770   C3539085:All [Idea or Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "respond to lovastatin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.334: It has been shown previously by immunostaining of livers from rats fed mevinolin (lovastatin) that HMGR expression is clustered around the blood supply (30). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously by immunostaining of livers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0023884:Livers [Body Part, Organ, or Organ Component]
   726 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   726 E C1278929:Liver [Body Part, Organ, or Organ Component]
   726 E C2346688:LIVER [Food]

Phrase: "from rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "mevinolin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Mevinolin [Organic Chemical,Pharmacologic Substance]

Phrase: "(lovastatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "that HMGR expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "clustered around the blood supply"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0005839:blood supply [Body Part, Organ, or Organ Component]
   806   C0678861:blood supply [Physiologic Function]
   806   C0920762:blood supply [Organ or Tissue Function]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0229664:Blood [Body Substance]
   760   C0243163:supply [Idea or Concept]
   760   C0699914:supply [Quantitative Concept]
   760   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   760   C1561604:supply [Functional Concept]
   760   C1875802:SUPPLY [Medical Device]
   760   C1999230:Supply [Activity]
   726   C1555715:Cluster [Idea or Concept]
   726   C1704332:Cluster [Quantitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.335: Uneven distribution of the drug could mean that some cells show a drastic up-regulation of HMGR message, whereas a larger percentage remains unaffected. 

Phrase: "Uneven distribution of the drug"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0870449:distribution drug [Human-caused Phenomenon or Process]
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "could"

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "that"

Phrase: "some cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a drastic up-regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "of HMGR message,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0470166:Message [Intellectual Product]

Phrase: "whereas"

Phrase: "a larger percentage remains"

Phrase: "unaffected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.336: Because in vivo footprinting examines the net promoter occupancy of a population of cells, the effect could be muted even though mRNA is markedly higher. 

Phrase: "Because"

Phrase: "in vivo footprinting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "examines"

Phrase: "the net promoter occupancy of a population of cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2827063:Occupancy [Qualitative Concept]

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "muted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1425601:MUTED [Gene or Genome]
   966 E C0278249:Mute [Finding]

Phrase: "even"

Phrase: "though"

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "markedly higher."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]
Processing 00000000.tx.337: In either case, the data suggest that insulin activation of this promoter occurs by a mechanism distinct from sterol regulation. 

Phrase: "In either case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin activation of this promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "occurs by a mechanism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "distinct from sterol regulation."
Processing 00000000.tx.338: View larger version (16K): [in this window] [in a new window]  FIGURE 11. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 11."
Processing 00000000.tx.339: Model of the HMGR promoter in normal and diabetic rat liver. 

Phrase: "Model of the HMGR promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3161035:Model [Intellectual Product]

Phrase: "in normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic rat liver."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.340: Schematic of the HMGR promoter showing the major elements that are occupied in vivo in normal or diabetic rats, along with putative factors bound to those elements.  

Phrase: "Schematic of the HMGR promoter"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the major elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013879:Elements [Element, Ion, or Isotope]
   861   C0205164:Major [Qualitative Concept]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "occupied"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548223:Occupied [Idea or Concept]

Phrase: "in vivo in normal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "or"

Phrase: "diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "along with putative factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "bound to those elements."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0013879:Elements [Element, Ion, or Isotope]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   737 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.341: The protections at 71/70 were not observed in footprints from diabetic animals. 

Phrase: "The protections at 71/70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1545588:Protection [Finding]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in footprints"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "from diabetic animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.342: It was found that NF-Y from nuclear extracts could bind to this element. 

Phrase: "It"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that NF-Y from nuclear extracts"

Phrase: "could"

Phrase: "bind to this element."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0013879:Element [Element, Ion, or Isotope]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1705248:Element [Conceptual Entity]
Processing 00000000.tx.343: Curiously, in vitro binding of NF-Y from nuclear extracts did not vary with diabetes, suggesting that other factors may be necessary to stabilize its interaction with the promoter in vivo. 

Phrase: "Curiously,"

Phrase: "in vitro binding of NF-Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "from nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "vary with diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "necessary to"

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "its interaction with the promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.344: This is the first identification of this NF-Y site in the HMGR promoter. 

Phrase: "This"

Phrase: "is"

Phrase: "the first identification of this NF-Y site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "in the HMGR promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.345: It is also clear that this site is of particular functional importance. 

Phrase: "It"

Phrase: "is"

Phrase: "also"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "is of particular functional importance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205245:Functional [Functional Concept]
   760   C0542341:Functional [Functional Concept]
   760   C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.346: Both mutations to this site substantially decreased overall transcription in H4IIE cells. 

Phrase: "Both mutations to this site substantially"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "overall transcription in H4IIE cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.347: Given its proximity to the transcription start site, recruitment of this factor is probably a key event in insulin regulation of HMGR. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "its proximity to the transcription start site,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514583:Proximity [Spatial Concept]

Phrase: "recruitment of this factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2949735:Recruitment [Activity]

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "a key event in insulin regulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441471:Event [Event]

Phrase: "of HMGR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.348: By using the information obtained from these experiments, we can construct a basic model of promoter occupancy in normal and diabetic rats (Fig. 11). 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "obtained from these experiments,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1706701:Obtain [Activity]

Phrase: "we"

Phrase: "can"

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "a basic model of promoter occupancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "in normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "(Fig. 11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.349: CREB is bound to the promoter at the CRE in both normal and diabetic rats. 

Phrase: "CREB"

Phrase: "is"

Phrase: "bound to the promoter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "at the CRE"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "in both normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.350: The previously described NF-Y site around 189/190 is occupied in both situations. 

Phrase: "The previously described NF-Y site around 189/190"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "occupied in both situations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1548223:Occupied [Idea or Concept]
Processing 00000000.tx.351: Sp1 or a related factor binds in the 119/142 region, possibly accounting for the enhancement at 138 in normal rats. 

Phrase: "Sp1"

Phrase: "or"

Phrase: "a related factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "binds in the 119/142 region,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "accounting for the enhancement"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0000938:Accounting [Occupational Activity]
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]
   737 E C1551359:account [Idea or Concept]
   737 E C2741673:Account # [Clinical Attribute]
   737 E C2981730:Account [Classification]

Phrase: "at 138"

Phrase: "in normal rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.352: This binding is likely prevented by the presence of a repressive factor that occupies the region between 142 and 161 in the diabetic animals. 

Phrase: "This binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "prevented by the presence of a repressive factor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0960756:factor A [Organic Chemical]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
   711   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "that"

Phrase: "occupies"

Phrase: "the region between 142"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "161 in the diabetic animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003062:Animals [Animal]
   760   C0241863:DIABETIC [Finding]
Processing 00000000.tx.353: The SRE is not protected to a detectable degree in the liver. 

Phrase: "The SRE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "protected to a detectable degree"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "in the liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.354: Although it is likely that SREBP-2 participates to some extent in basal transcription, it is not known what percentage of endogenous SREBPs are bound to the hepatic HMGR promoter under normal conditions. 

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that SREBP-2"

Phrase: "participates to some extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "in basal transcription,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040649:Transcription [Genetic Function]

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "what percentage of endogenous SREBPs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "are"

Phrase: "bound to the hepatic HMGR promoter"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205054:Hepatic [Body Location or Region]
   739   C0332297:bound [Spatial Concept]
   739   C0700307:Hydroxy [Inorganic Chemical]
   739   C1145667:Bound [Activity]
   739   C1167622:Bound [Molecular Function]
   739   C1689898:% bound [Quantitative Concept]
   739   C2349209:Bound [Conceptual Entity]

Phrase: "under normal conditions."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   983   C0231162:Normal condition [Finding]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.355: The diagram also shows a newly identified NF-Y site at 71/70 that is preferentially occupied in the normal animals. 

Phrase: "The diagram also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681494:Diagram [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a newly identified NF-Y site at 71/70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "preferentially"

Phrase: "occupied in the normal animals."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0003062:Animals [Animal]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1548223:Occupied [Idea or Concept]
   760   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.356: In summary, the areas of protection or enhancement identified in this study generally correspond with the large protected regions seen previously in DNase I footprinting studies of the hamster promoter (19). 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "the areas of protection"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0205146:areas [Spatial Concept]
   737 E C0017446:Area [Geographic Area]

Phrase: "or"

Phrase: "enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1627358:Enhancement [Therapeutic or Preventive Procedure]
  1000   C2349975:Enhancement [Activity]

Phrase: "identified in this study generally"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205396:Identified [Qualitative Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C2603343:Study [Research Activity]

Phrase: "correspond with the large protected regions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0549177:Large [Quantitative Concept]
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "previously in DNase I footprinting studies of the hamster promoter"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   782   C1512007:DNase-I Footprinting [Molecular Biology Research Technique]
   760   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
           DNase
   760   C1148702:DNase I [Genetic Function]
   739   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0018557:Hamster [Mammal]
   739   C0021966:I- [Inorganic Chemical]
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0947630:studies [Laboratory Procedure]
   706 E C0557651:Study [Manufactured Object]
   706 E C2603343:Study [Research Activity]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.357: Previous in vivo footprints of the human promoter in HepG2 cells did not find any differences with insulin treatment, despite a 1.5-fold increase in mRNA (20). 

Phrase: "Previous in vivo footprints of the human promoter"

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "any differences with insulin treatment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "despite a 1.5-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0442805:Increase [Functional Concept]

Phrase: "in mRNA (20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.358: These previous in vivo studies also identified the SRE as a protected region, something that was not observed in rat liver. 

Phrase: "These previous in vivo studies also"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   867   C0681829:in vivo study [Research Activity]
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the SRE as a protected region,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0013879:Element [Element, Ion, or Isotope]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1705248:Element [Conceptual Entity]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
   731   C1709736:Protection Element [Conceptual Entity]

Phrase: "something"

Phrase: "that"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in rat liver."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1441672:Observed [Functional Concept]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.359: These reports were useful in both helping us design the experiments and in allowing us to compare results from cultured tumor cells to rat liver. 

Phrase: "These reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "were"

Phrase: "useful in both helping"

Phrase: "us"

Phrase: "design"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1707689:Design [Activity]
  1000   C2983265:DESIGN [Intellectual Product]

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "and in allowing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0683607:allowing [Social Behavior]
   790   C1515981:And [Idea or Concept]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "results from cultured tumor cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "to rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.360: Our work represents the first examination of the in vivo occupancy of the hepatic HMGR promoter in live animals. 

Phrase: "Our work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the first examination of the in vivo occupancy"

Phrase: "of the hepatic HMGR promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in live animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.361: This is also the first demonstration that the CRE is occupied in vivo. 

Phrase: "This"

Phrase: "is"

Phrase: "also"

Phrase: "the first demonstration"

Phrase: "that"

Phrase: "the CRE"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "is"

Phrase: "occupied"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548223:Occupied [Idea or Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.362: We report a novel NF-Y site that is more often protected in normal animals and is required for efficient HMGR transcription. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "a novel NF-Y site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "more often"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332183:Often [Temporal Concept]

Phrase: "protected in normal animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003062:Animals [Animal]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "required for efficient HMGR transcription."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0040649:Transcription [Genetic Function]
   742   C0442799:Efficient [Qualitative Concept]
   742   C0700307:Hydroxy [Inorganic Chemical]
   742   C1514873:Required [Functional Concept]
Processing 00000000.tx.363: Most importantly, we have identified a few key areas where occupancy varies with diabetes, particularly 138, 142, and 161. 

Phrase: "Most importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a few key areas where occupancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2827063:Occupancy [Qualitative Concept]

Phrase: "varies with diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1548673:Varies [Intellectual Product]

Phrase: "particularly 138,"

Phrase: "142,"

Phrase: "and"

Phrase: "161."
Processing 00000000.tx.364: This work will help focus future studies of insulin activation of this promoter and further our understanding of the transcriptional regulation of genes in the liver. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "will"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "focus future studies of insulin activation of this promoter"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0947630:studies [Laboratory Procedure]
   708 E C0557651:Study [Manufactured Object]
   708 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "our understanding of the transcriptional regulation of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162340:Understanding [Mental Process]

Phrase: "in the liver."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.365: Additional studies are needed to address the functional roles of these footprinted elements in the context of the live animal. 

Phrase: "Additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the functional roles of these footprinted elements"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1705810:Functional Role [Conceptual Entity]
       E   Role
   748   C0035820:Roles [Social Behavior]

Phrase: "in the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of the live animal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animal [Animal]
Processing 00000000.tx.366: Such investigations into insulin regulation of cholesterol biosynthesis are of paramount importance if we are to understand the links between diabetes and cardiovascular disease.  

Phrase: "Such investigations into insulin regulation of cholesterol biosynthesis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1261322:Investigations [Health Care Activity]
   711 E C1552578:investigation [Idea or Concept]

Phrase: "are of paramount importance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1551058:Are [Quantitative Concept]

Phrase: "if"

Phrase: "we"

Phrase: "are"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the links between diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "cardiovascular disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007222:Cardiovascular disease [Disease or Syndrome]
   861   C0007226:Cardiovascular [Body System]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.367: FOOTNOTES  * This work was supported by Grant 04-TSP-03 from the Florida Department of Health. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Grant 04-TSP-03"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0018173:Grant [Quantitative Concept]
   753   C1521721:Supported [Conceptual Entity]
   753   C1548284:Grant [Idea or Concept]
   719 E C0183683:Support [Medical Device]

Phrase: "from the Florida Department"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704729:Department [Organization]

Phrase: "of Health."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018684:Health [Idea or Concept]
   900 E C0031206:healthiness [Finding]
Processing 00000000.tx.368: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.369: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.370: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.371: 1 To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, College of Medicine, University of South Florida, 12901 Bruce B. 

Phrase: "1 To whom correspondence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282413:Correspondence [Intellectual Product]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0557806:College [Manufactured Object]

Phrase: "University of South Florida,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016253:Florida [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1710133:South [Spatial Concept]

Phrase: "12901 Bruce B."
Processing 00000000.tx.372: Downs Blvd., Tampa, FL 33612. 

Phrase: "Downs Blvd.,"

Phrase: "Tampa,"

Phrase: "FL 33612."
Processing 00000000.tx.373: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.374: 813-974-9596; 

Phrase: "813-974-9596"

Phrase: ";"
Processing 00000000.tx.375: Fax: 813-974-5798; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "813-974-5798"

Phrase: ";"
Processing 00000000.tx.376: E-mail: gness{at}hsc.usf.edu . 2 The abbreviations used are: HMG, 3-hydroxy-3-methylglutaryl; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "gness{at}hsc.usf.edu . 2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   799   C0076925:USF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1523748:HSC [Cell Component]
   799   C1705576:HSC [Therapeutic or Preventive Procedure]
   799   C1706445:USF [Gene or Genome]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "HMG,"

Phrase: "3-hydroxy-3-methylglutaryl"

Phrase: ";"
Processing 00000000.tx.377: HMGR, 3-hydroxy-3-methylglutaryl-coenzyme A reductase; 

Phrase: "HMGR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "3-hydroxy-3-methylglutaryl-coenzyme A reductase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0063164:3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   787   C0047420:3-hydroxy-3-methylglutaryl-coenzyme A [Biologically Active Substance,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.378: SRE, sterol-response element; 

Phrase: "SRE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "sterol-response element"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: ";"
Processing 00000000.tx.379: SREBP, sterol-response element-binding protein; 

Phrase: "SREBP,"

Phrase: "sterol-response element-binding protein"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   937   C1819645:sterol response element binding [Genetic Function]
   875   C2246292:sterol binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0038323:Sterol [Steroid]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: ";"
Processing 00000000.tx.380: CRE, cyclic AMP-response element; 

Phrase: "CRE,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: "cyclic AMP-response element"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1511573:Cyclic AMP Response Element [Gene or Genome]
   861   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0439596:Cyclic [Temporal Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1511572:Cyclic [Temporal Concept]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   741 E C0031084:Cyclicities [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.381: CREB, cyclic AMP-response element-binding protein; 

Phrase: "CREB,"

Phrase: "cyclic AMP-response element-binding protein"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
  1000   C0056695:Cyclic AMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C3158668:cyclic-AMP response element binding [Genetic Function]
   901   C1511573:Cyclic AMP Response Element [Gene or Genome]
   885   C1148918:cyclic AMP binding [Molecular Function]
   858   C1148922:AMP binding [Molecular Function]
   827   C0001455:Cyclic AMP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0013879:Element [Element, Ion, or Isotope]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C0439596:Cyclic [Temporal Concept]
   799   C0871261:Response [Organism Attribute]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1511572:Cyclic [Temporal Concept]
   799   C1704632:Response [Finding]
   799   C1705248:Element [Conceptual Entity]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]
   727 E C0031084:Cyclicities [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.382: HepG2, human hepatoma cell line; 

Phrase: "HepG2,"

Phrase: "human hepatoma cell line"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   923   C0682523:Human Cell Line [Cell]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0007600:Cell Line [Cell]
   861   C0677626:hepatoma cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0023903:Hepatoma [Neoplastic Process]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C2239176:Hepatoma [Neoplastic Process]

Phrase: ";"
Processing 00000000.tx.383: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.384: DMS, dimethyl sulfate; 

Phrase: "DMS,"

Phrase: "dimethyl sulfate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0058229:Dimethylsulfate [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0038720:Sulfate [Inorganic Chemical]
   861   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   861   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.385: EMSA, electrophoretic mobility shift assay; 

Phrase: "EMSA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596608:EMSA [Diagnostic Procedure]
  1000   C0949632:EMSA [Laboratory Procedure]

Phrase: "electrophoretic mobility shift assay"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0949632:Electrophoretic Mobility Shift Assay [Laboratory Procedure]
           Mobility Shift Assay
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C0333051:Shift [Functional Concept]
   812   C0425245:Mobility [Finding]
   812   C0449580:Mobility [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   812   C2347509:Shift [Phenomenon or Process]
   741   C0013855:Electrophoreses [Laboratory Procedure]
   741 E C0231435:Mobile [Functional Concept]
   741 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: ";"
Processing 00000000.tx.386: TBE, Tris borate/EDTA; 

Phrase: "TBE,"

Phrase: "Tris borate/EDTA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0006007:Borate [Chemical Viewed Structurally]
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.387: USF-2, upstream stimulatory factor 2.  

Phrase: "USF-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0076925:USF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1706445:USF [Gene or Genome]

Phrase: "upstream stimulatory factor 2."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1421377:UPSTREAM STIMULATORY FACTOR 2 [Gene or Genome]
  1000   C1447047:Upstream Stimulatory Factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0076925:Upstream Stimulatory Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0522505:Upstream [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.388: ACKNOWLEDGMENTS  We thank Dayami Lopez for input on nuclear run-on assays. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dayami Lopez for input"

Phrase: "on nuclear run-on assays."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1519116:Run-On Assays [Molecular Biology Research Technique]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.389: We thank Kenneth Wright, Jian Wu, and Sophie Bolick for the invaluable advice on in vivo footprinting. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Kenneth Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "Jian Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Sophie Bolick for the invaluable advice"

Phrase: "on in vivo footprinting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1515655:In Vivo [Spatial Concept]
Processing 00000000.tx.390: We also thank Louis Crowley and Glenn Roma for providing advice on site-directed mutagenesis.  

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Louis Crowley"

Phrase: "and"

Phrase: "Glenn Roma for providing advice on site-directed mutagenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0445583:Roma [Intellectual Product]
   742   C1514862:ROMA [Molecular Biology Research Technique]
Processing 00000000.tx.391: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Miettinen, T. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Miettinen,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.392: A., Gylling, H., Tuominen, J., Simonen, P., and Koivisto, V. 

Phrase: "A.,"

Phrase: "Gylling,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tuominen,"

Phrase: "J.,"

Phrase: "Simonen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Koivisto,"

Phrase: "V."
Processing 00000000.tx.393: (2004) Diabetes Care 27, 5358[Abstract/Free FullText] Armitage, J., and Bowman, L. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Diabetes Care 27,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: "5358"

Phrase: "[Abstract/Free FullText"

Phrase: "] Armitage,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Bowman,"

Phrase: "L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.394: (2004) Curr. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.395: Opin. 

Phrase: "Opin."
Processing 00000000.tx.396: Lipidol. 

Phrase: "Lipidol."
Processing 00000000.tx.397: 15, 439446[CrossRef][Medline] [OrderarticleviaInfotrieve] Ness, G. 

Phrase: "15,"

Phrase: "439446"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ness,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1417679:NES [Gene or Genome]
   966   C1504638:Nes [Fish]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.398: C., and Gertz, K. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Gertz,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.399: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.400: (2004) Exp. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.401: Biol. 

Phrase: "Biol."
Processing 00000000.tx.402: Med. 

Phrase: "Med."
Processing 00000000.tx.403: 229, 407411[Abstract/Free FullText] Ness, G. 

Phrase: "229,"

Phrase: "407411"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ness,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1417679:NES [Gene or Genome]
   966   C1504638:Nes [Fish]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.404: C., and Gertz, K. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Gertz,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.405: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.406: (2004) Exp. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.407: Biol. 

Phrase: "Biol."
Processing 00000000.tx.408: Med. 

Phrase: "Med."
Processing 00000000.tx.409: 229, 412416[Abstract/Free FullText] Ness, G. 

Phrase: "229,"

Phrase: "412416"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ness,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1417679:NES [Gene or Genome]
   966   C1504638:Nes [Fish]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.410: C., and Chambers, C. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Chambers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "C."
Processing 00000000.tx.411: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.412: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.413: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.414: Biol. 

Phrase: "Biol."
Processing 00000000.tx.415: Med. 

Phrase: "Med."
Processing 00000000.tx.416: 224, 819[Abstract/Free FullText] Ness, G. 

Phrase: "224,"

Phrase: "819"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ness,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1417679:NES [Gene or Genome]
   966   C1504638:Nes [Fish]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.417: C., Wiggins, L., and Zhao, Z. 

Phrase: "C., Wiggins,"

Phrase: "L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Zhao,"

Phrase: "Z."
Processing 00000000.tx.418: (1994) Arch. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.419: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.420: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.421: 309, 193194[CrossRef][Medline] [OrderarticleviaInfotrieve] Osborne, A. 

Phrase: "309,"

Phrase: "193194"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Osborne,"

Phrase: "A."
Processing 00000000.tx.422: R., Pollock, V. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Pollock,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0328442:Pollock [Fish]
  1000   C0453004:Pollack [Food]

Phrase: "V."
Processing 00000000.tx.423: V., Lagor, W. 

Phrase: "V., Lagor,"

Phrase: "W."
Processing 00000000.tx.424: R., and Ness, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Ness,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1417679:NES [Gene or Genome]
   966   C1504638:Nes [Fish]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.425: C. 

Phrase: "C."
Processing 00000000.tx.426: (2004) Biochem. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.427: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.428: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.429: Commun. 

Phrase: "Commun."
Processing 00000000.tx.430: 318, 814818[CrossRef][Medline] [OrderarticleviaInfotrieve] Osborne, T. 

Phrase: "318,"

Phrase: "814818"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Osborne,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.431: F., Goldstein, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Goldstein,"

Phrase: "J."
Processing 00000000.tx.432: L., and Brown, M. 

Phrase: "L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.433: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.434: (1985) Cell 42, 203212[CrossRef][Medline] [OrderarticleviaInfotrieve] Osborne, T. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Cell 42,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "203212"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Osborne,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.435: F., Gil, G., Goldstein, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Gil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412493:GIL [Gene or Genome]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Goldstein,"

Phrase: "J."
Processing 00000000.tx.436: L., and Brown, M. 

Phrase: "L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.437: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.438: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.439: Biol. 

Phrase: "Biol."
Processing 00000000.tx.440: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.441: 263, 33803387[Abstract/Free FullText] Bifulco, M., Perillo, B., Saji, M., Laezza, C., Tedesco, I., Kohn, L. 

Phrase: "263,"

Phrase: "33803387"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bifulco,"

Phrase: "M."

Phrase: ","

Phrase: "Perillo,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Saji,"

Phrase: "M."

Phrase: ","

Phrase: "Laezza,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Tedesco,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kohn,"

Phrase: "L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.442: D., and Aloj, S. 

Phrase: "D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "Aloj,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.443: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.444: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.445: Biol. 

Phrase: "Biol."
Processing 00000000.tx.446: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.447: 270, 1523115236[Abstract/Free FullText] Vallett, S. 

Phrase: "270,"

Phrase: "1523115236"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vallett,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.448: M., Sanchez, H. 

Phrase: "M."

Phrase: ","

Phrase: "Sanchez,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.449: B., Rosenfeld, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rosenfeld,"

Phrase: "J."
Processing 00000000.tx.450: M., and Osborne, T. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Osborne,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.451: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.452: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.453: Biol. 

Phrase: "Biol."
Processing 00000000.tx.454: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.455: 271, 1224712253[Abstract/Free FullText] Bennett, M. 

Phrase: "271,"

Phrase: "1224712253"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bennett,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.456: K., Toth, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Toth,"

Phrase: "J."
Processing 00000000.tx.457: I., and Osborne, T. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Osborne,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.458: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.459: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.460: Biol. 

Phrase: "Biol."
Processing 00000000.tx.461: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.462: 279, 3736037367[Abstract/Free FullText] Kersten, S. 

Phrase: "279,"

Phrase: "3736037367"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kersten,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.463: (2001) EMBO Rep. 

Phrase: "(2001"

Phrase: ")"

Phrase: "EMBO Rep."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1744664:REP [Molecular Function]
Processing 00000000.tx.464: 2, 282286[Abstract/Free FullText] Shimano, H., Horton, J. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "282286"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Horton,"

Phrase: "J."
Processing 00000000.tx.465: D., Hammer, R. 

Phrase: "D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "Hammer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0181107:Hammer [Manufactured Object]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.466: E., Shimomura, I., Brown, M. 

Phrase: "E.,"

Phrase: "Shimomura,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.467: S., and Goldstein, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Goldstein,"

Phrase: "J."
Processing 00000000.tx.468: L. 

Phrase: "L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.469: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.470: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.471: Investig. 

Phrase: "Investig."
Processing 00000000.tx.472: 98, 15751584[Abstract/Free FullText] Horton, J. 

Phrase: "98,"

Phrase: "15751584"

Phrase: "[Abstract/Free FullText"

Phrase: "] Horton,"

Phrase: "J."
Processing 00000000.tx.473: D., Shimomura, I., Brown, M. 

Phrase: "D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "Shimomura,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.474: S., Hammer, R. 

Phrase: "S."

Phrase: ","

Phrase: "Hammer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0181107:Hammer [Manufactured Object]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.475: E., Goldstein, J. 

Phrase: "E.,"

Phrase: "Goldstein,"

Phrase: "J."
Processing 00000000.tx.476: L., and Shimano, H. 

Phrase: "L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Shimano,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.477: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.478: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.479: Investig. 

Phrase: "Investig."
Processing 00000000.tx.480: 101, 23312339[Abstract/Free FullText] Osborne, T. 

Phrase: "101,"

Phrase: "23312339"

Phrase: "[Abstract/Free FullText"

Phrase: "] Osborne,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.481: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.482: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.483: Biol. 

Phrase: "Biol."
Processing 00000000.tx.484: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.485: 275, 3237932382[Free FullText] Mueller, P. 

Phrase: "275,"

Phrase: "3237932382"

Phrase: "[Free FullText"

Phrase: "] Mueller,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.486: R., and Wold, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Wold,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.487: (1989) Science 246, 780786[Medline] [OrderarticleviaInfotrieve] Bossard, P., McPherson, C. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Science 246,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "780786"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bossard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "McPherson,"

Phrase: "C."
Processing 00000000.tx.488: E., and Zaret, K. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Zaret,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.489: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.490: (1997) Methods 11, 180188[CrossRef][Medline] [OrderarticleviaInfotrieve] Osborne, T. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Methods 11,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "180188"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Osborne,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.491: F., Gil, G., Brown, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Gil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412493:GIL [Gene or Genome]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.492: S., Kowal, R. 

Phrase: "S."

Phrase: ","

Phrase: "Kowal,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.493: C., and Goldstein, J. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Goldstein,"

Phrase: "J."
Processing 00000000.tx.494: L. 

Phrase: "L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.495: (1987) Proc. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.496: Natl. 

Phrase: "Natl."
Processing 00000000.tx.497: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.498: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.499: U. 

Phrase: "U."
Processing 00000000.tx.500: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.501: A. 

Phrase: "A."
Processing 00000000.tx.502: 84, 36143618[Abstract/Free FullText] Lloyd, D. 

Phrase: "84,"

Phrase: "36143618"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lloyd,"

Phrase: "D."
Processing 00000000.tx.503: B., and Thompson, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Thompson,"

Phrase: "J."
Processing 00000000.tx.504: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.505: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.506: Biol. 

Phrase: "Biol."
Processing 00000000.tx.507: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.508: 270, 2581225818[Abstract/Free FullText] Mano, H., Mori, R., Ozawa, T., Takeyama, K. 

Phrase: "270,"

Phrase: "2581225818"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mori,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ozawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takeyama,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.509: I., Yoshizawa, Y., Kojima, R., Arao, Y., Masushigo, S., and Kato, S. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yoshizawa,"

Phrase: "Y.,"

Phrase: "Kojima,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Arao,"

Phrase: "Y.,"

Phrase: "Masushigo,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.510: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.511: Biol. 

Phrase: "Biol."
Processing 00000000.tx.512: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.513: 269, 15911594[Abstract/Free FullText] Lopez, D., Chambers, C. 

Phrase: "269,"

Phrase: "15911594"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lopez,"

Phrase: "D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "Chambers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "C."
Processing 00000000.tx.514: M., and Ness, G. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ness,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1417679:NES [Gene or Genome]
   966   C1504638:Nes [Fish]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.515: C. 

Phrase: "C."
Processing 00000000.tx.516: (1997) Arch. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.517: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.518: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.519: 343, 118122[CrossRef][Medline] [OrderarticleviaInfotrieve] Yu, C. 

Phrase: "343,"

Phrase: "118122"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C."
Processing 00000000.tx.520: L., Meyer, D. 

Phrase: "L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "Meyer,"

Phrase: "D."
Processing 00000000.tx.521: J., Campbell, G. 

Phrase: "J.,"

Phrase: "Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.522: S., Larner, A. 

Phrase: "S."

Phrase: ","

Phrase: "Larner,"

Phrase: "A."
Processing 00000000.tx.523: C., Carter-Su, C., Schwartz, J., and Jove, R. 

Phrase: "C., Carter-Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705534:SU [Idea or Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schwartz,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Jove,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.524: (1995) Science 269, 8183[Medline] [OrderarticleviaInfotrieve] Latasa, M. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "8183"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Latasa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.525: J., Griffin, M. 

Phrase: "J.,"

Phrase: "Griffin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.526: J., Moon, Y. 

Phrase: "J.,"

Phrase: "Moon,"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
  1000   C0079853:Moon [Geographic Area]
   916 E C0037125:Silver [Element, Ion, or Isotope]
   916 E C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   916 E C1305285:Silver [Qualitative Concept]
   916 E C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   884 E C0003782:Argyria [Injury or Poisoning]
   884 E C3463959:Argyria [Eukaryote]

Phrase: "Y."
Processing 00000000.tx.527: S., and Sul, H. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Sul,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.528: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.529: (2003) Mol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.530: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.531: Biol. 

Phrase: "Biol."
Processing 00000000.tx.532: 23, 58965907[Abstract/Free FullText] Bennett, M. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "58965907"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bennett,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.533: K., and Osborne, T. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Osborne,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.534: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.535: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.536: Natl. 

Phrase: "Natl."
Processing 00000000.tx.537: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.538: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.539: U. 

Phrase: "U."
Processing 00000000.tx.540: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.541: A. 

Phrase: "A."
Processing 00000000.tx.542: 97, 63406344[Abstract/Free FullText] Chambers, C. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "63406344"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chambers,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0179874:chambers [Medical Device]
   966 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "C."
Processing 00000000.tx.543: M., and Ness, G. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ness,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1417679:NES [Gene or Genome]
   966   C1504638:Nes [Fish]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.544: C. 

Phrase: "C."
Processing 00000000.tx.545: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.546: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.547: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.548: Commun. 

Phrase: "Commun."
Processing 00000000.tx.549: 232, 278281[CrossRef][Medline] [OrderarticleviaInfotrieve] Kriwacki, R. 

Phrase: "232,"

Phrase: "278281"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kriwacki,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.550: W., Schultz, S. 

Phrase: "W., Schultz,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.551: C., Steitz, T. 

Phrase: "C., Steitz,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.552: A., and Caradonna, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Caradonna,"

Phrase: "J."
Processing 00000000.tx.553: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.554: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.555: Natl. 

Phrase: "Natl."
Processing 00000000.tx.556: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.557: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.558: U. 

Phrase: "U."
Processing 00000000.tx.559: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.560: A. 

Phrase: "A."
Processing 00000000.tx.561: 89, 97599763[Abstract/Free FullText] Ngo, T. 

Phrase: "89,"

Phrase: "97599763"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ngo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.562: T., Bennett, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bennett,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.563: K., Bourgeois, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bourgeois,"

Phrase: "A."
Processing 00000000.tx.564: L., Toth, J. 

Phrase: "L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024027:Lovastatin [Organic Chemical,Pharmacologic Substance]

Phrase: "Toth,"

Phrase: "J."
Processing 00000000.tx.565: I., and Osborne, T. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Osborne,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.566: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.567: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.568: Biol. 

Phrase: "Biol."
Processing 00000000.tx.569: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.570: 277, 3390133905[Abstract/Free FullText] Zhang, C., Shin, D. 

Phrase: "277,"

Phrase: "3390133905"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Shin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230444:Shin [Body Location or Region]

Phrase: "D."
Processing 00000000.tx.571: J., and Osborne, T. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Osborne,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.572: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.573: (2005) Biochem. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.574: J. 

Phrase: "J."
Processing 00000000.tx.575: 386, 161168[CrossRef][Medline] [OrderarticleviaInfotrieve] Singer, I. 

Phrase: "386,"

Phrase: "161168"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Singer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335076:Singer [Professional or Occupational Group]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.576: I., Kawka, D. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kawka,"

Phrase: "D."
Processing 00000000.tx.577: W., Kazazis, D. 

Phrase: "W., Kazazis,"

Phrase: "D."
Processing 00000000.tx.578: M., Alberts, A. 

Phrase: "M."

Phrase: ","

Phrase: "Alberts,"

Phrase: "A."
Processing 00000000.tx.579: W., Chen, J. 

Phrase: "W., Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0999213:Chen [Bird]

Phrase: "J."
Processing 00000000.tx.580: S., Huff, J. 

Phrase: "S."

Phrase: ","

Phrase: "Huff,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0566520:huff [Finding]

Phrase: "J."
Processing 00000000.tx.581: W., and Ness, G. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Ness,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1417679:NES [Gene or Genome]
   966   C1504638:Nes [Fish]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.582: C. 

Phrase: "C."
Processing 00000000.tx.583: (1984) Proc. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.584: Natl. 

Phrase: "Natl."
Processing 00000000.tx.585: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.586: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.587: U. 

Phrase: "U."
Processing 00000000.tx.588: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.589: A. 

Phrase: "A."
Processing 00000000.tx.590: 81, 55565560[Abstract/Free FullText] This Article Abstract Full Text (PDF) All Versions of this Article: 280/44/36601 most recent M504346200v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Permissions Google Scholar Articles by Lagor, W. 

Phrase: "81,"

Phrase: "55565560"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "280/44/36601 most recent M504346200v1 Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C0441061:Shopping cart [Manufactured Object]
   788   C0179636:Cart [Manufactured Object]
   788   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Copyright Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Lagor,"

Phrase: "W."
Processing 00000000.tx.591: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.592: Articles by Ness, G. 

Phrase: "Articles by Ness,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.593: C. 

Phrase: "C."
Processing 00000000.tx.594: PubMed PubMed Citation Articles by Lagor, W. 

Phrase: "PubMed PubMed Citation Articles by Lagor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "W."
Processing 00000000.tx.595: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.596: Articles by Ness, G. 

Phrase: "Articles by Ness,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.597: C. 

Phrase: "C."
Processing 00000000.tx.598: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular and Cellular Proteomics Journal of Lipid Research Biochemistry and Molecular Biology Education Copyright  2005 by the American Society for Biochemistry and Molecular Biology.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "All ASBMB Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Proteomics Journal of Lipid Research Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Molecular Biology Education Copyright  2005 by the American Society"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   742   C0005532:Biology [Biomedical Occupation or Discipline]
   742   C0009993:Copyright [Intellectual Product]
   742   C0013621:Education [Educational Activity]
   742   C0013622:education [Classification]
   742   C0013658:Education, NOS [Finding]
   742   C0037455:society [Organization]
   742   C0039401:Education [Educational Activity]
   742   C0596070:American [Population Group]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

